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1 ABSTRACT 
C. albicans is a ubiquitous fungal organism that often colonizes the skin and the 
mucosal surfaces of healthy individuals, without causing disease. However, when the 
normal host defence mechanisms are impaired, C. albicans can become a pathogen. 
Candidaemia has an incidence of between 1.1 and 24 cases per 100,000 individuals and an 
associated mortality rate of more than 30%. Thus, the elucidation of the mechanisms of the 
interactions of C. albicans and the host is not only a highly relevant research topic, but also 
can lead to the identification of novel targets and promising compounds for treating C. 
albicans infections. 
We chose as chemical compound the isoflavone genistein for our studies. Genistein is 
a well known natural compound which is present in soy foods and exerts many beneficial 
functions (anticancer, anti-inflammatory, antioxidant). However, until now little is known 
about the effects of genistein on C. albicans, the function of macrophages, and the 
interactions between both organisms. We used the murine macrophage cell line RAW264.7 
as target cell line. We found that genistein could influence macrophage functions: at 
concentrations of 100 - 50 µM, genistein reduced the cell viability to 70 % - 80 % (after 24 
h) and 50 % - 60 % (after 48h), which was due to G2/M phase cell cycle arrest. Treatment 
of the macrophages with genistein for 24 or 48 h also led to significant morphological 
changes, such as elongation of the cells and development of long pseudopodia-like 
protrusions. By staining the F-actin cytoskeleton, we observed accumulation of actin - 
filaments at the edges of the cells. Phagoyctosis is one of most important functions of 
macrophages. After treatment of the macrophages with genistein, the phagocytotic 
efficiency for C. albicans was decreased in a time- and dose-dependent manner. Moreover, 
the production of cytokines (TNF-α, IL-10) stimulated by C. albicans was strongly 
inhibited by genistein. Genistein also blocked the response of macrophages to bacterial 
stimulants, such as LPS, i.e. the secretion of NO, TNF-α, and IL-10, which is related to the 
inhibition of the activation of transcription factors NF-κB and AP-1.  
Additionally, we investigated whether genistein could directly influence the pathogen, 
C. albicans. Our results showed that genistein blocked oxygen consumption of C. albicans 
and induced the production of reactive oxygen species. However, those effects were not 
observed in S. cerevisiae. C. albicans and S. cerevisiae significantly differ in the 
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composition of the respiratory chain, as in S. cerevisiae complex I is absent. From 
comparison with rotenone (specific complex I inhibitor) and antimycin A (specific complex 
III inhibitor), we concluded that complex I is the most likely target for genistein. Using 
DCIP as a mediator, we detected complex I reductase activity. Genistein did not act as an 
inhibitor of DCIP reduction by complex I as rotenone did. The results pointed out that 
genistein binds to complex I of C. albicans at a site different from that of rotenone. 
Moreover, treatment of C. albicans with genistein enhanced the susceptibilty of the 
pathogen for phagocytosis by the macrophages and increased the production of the 
cytokines IL-10 and TNF-α. However, genistein did not influence the structure of the cell 
wall glucans and mannans of C. albicans, which was analysed by flow cytometry; whereas 
the cell surface hydrophobicity, which correlates with adherence, increased. 
In conclusion, genistein could influence both the functions of host macrophages and 
the properties of the pathogen C. albicans. Thus, genistein may have antimycotic effects by 
acting on C. albicans to enhance the phagocytic activity of macrophages.
2  Introduction                                                                                  3                      
 
2 INTRODUCTION 
Natural products, especially isoflavones, have attracted many attentions from scientists 
due to their natural origins and low side effects. Isoflavones are present in food, especially 
in soybean and some Chinese herbs. Their beneficial health effects are well studied, in 
particular with respect to cancer treatment.  
With the widespread use of broad-spectrum antibiotics, spread of AIDS, in particular, 
immunosuppressive agents in therapy cancer treatment, the incidence of C. albicans 
infections increased year by year. Candidiasis accounted for 82 % of all fungal infections. 
Although prevention and treatment of C. albicans infections has made great progress, the 
mortality rate is still high. Due to the commensal nature of these pathogens, prevention of 
the outbreak of infections by the long term use of healthy food components is one of the 
promising and challenging research topics. Therefore, in these studies, we focus on the 
influence of the food constituent genistein on the co-existence of C. albicans and host cells, 
in particular macrophages. 
2.1 Pharmacological activity of genistein 
Flavonoids belong to a polyphenol subclass and are widely distributed in the plant 
kingdom. They are chemically categorized into different subtypes based on the connection 
of an aromatic ring to the heterocyclic ring as well as the oxidation state and functional 
groups of the heterocyclic ring (Tab. 2.1) [1]. Flavonoids are found in fruits, vegetables, 
legumes, herbs, spices, stems, flowers, as well as tea and red wine. They are consumed 
regularly in many countries in a healthy diet.  
Natural flavonoids and isoflavonoids are currently of great interest due to their 
antioxidative and anticancer properties. Genistein (4’, 5, 7-trihydroxyisoflavone) (Fig. 2.1), 
a well studied isoflavone, is a major constituent of soyfoods and legumes such as lupin, 
fava beans, soybeans, kudzu, psoralea, and chickpeas. It shows a variety of biological 
effects, for example as a phytoestrogen or anti-cancer agent etc., but here we focus on the 
pharmacological activity related to microbial infections.  
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Tab. 2.1 Classification, prominent food flavonoids and typical food sources 
 
Flavonoid class Food flavonoid Food source 
Flavanols Catechin, gallocatechin, epicatechin Teas,red grapes and red wine 
Flavanones Naringenin, hesperetin, eriodictyol, 
taxifolin 
Citrus foods 
Flavones Apigenin, luteolin, rutin chrysin Green leafy spices 
Isoflavones Daidzein, genistein, glycitein, 
biochanin A, daidzin 
Soybeans,soy foods and legumes 
Flavonols Kaempferol, myricetin, quercetin, 
isorhamnetin, tamarixetin 
Nearly ubiquitous in foods 
Anthocyanidins Cyanidin, delphinidin, pelargonidin, 
apigenidin 
Red, purple and blue berries 
 
 
Fig. 2.1 Structure of genistein 
 
2.1.1 Bioavailability of dietary genistein 
Most flavonoids exist in plants as glycosidic conjugates, generally located in cell 
vacuoles. Bioavailability of these dietary components depends on relative uptake rates of 
conjugated and free forms, hydrolysis of glycosides by gut bacteria or gut wall enzymes, 
further metabolism such as glucuronides pathway within the liver, and excretion rates. The 
malonyl glucosides of daidzein and genistein found in soybeans are labile and are readily 
degraded to the non-acylated glucosides following cooking. The free aglycones, but not the 
glycosides, are absorbed from rat stomach. However, once in the small intestine, brush 
border lactase phlorizin hydrolase can effectively hydrolyze isoflavone glucosides. 
Nevertheless, in humans, isoflavones appear in blood plasma at a more rapid rate and at 
higher levels, following oral administration of aglycones as compared to glycosides. 
Moreover, genistein and daidzein, but not their glycosides, are readily transported across 
human intestinal epithelial cell monolayers [2].  
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2.1.2 Genistein as a tyrosine kinase inhibitor 
Tyrosine kinase is an enzyme that transfers a phosphate group from high energy donor 
molecules such as ATP to tyrosine residues of proteins. It plays an important role in 
regulation signal transduction in human cells. Genistein was reported as a tyrosine kinase 
inhibitor by Akiyama in 1987 [3]. Genistein exerts anti-inflammatory and anti-infection 
effects due to this kinase inhibitiory property which will be described in the related 
paragraph. 
2.1.3 Genistein as an antioxidant 
Cells and tissues in the body are continuously threatened by damage caused by free 
radicals and reactive oxygen species, which are produced during normal oxygen 
metabolism or are induced by exogenous factors [4]. The increased production of reactive 
oxygen species accompany most forms of tissue injury, which have been implicated in a 
multitude of disease states ranging from inflammatory injury to myocardial infarction and 
cancer [5]. Genistein has been shown to protect cells against reactive oxygen species (ROS) 
by scavenging free radicals and reducing the expression of stress-response related genes [6, 
7]. Genistein inhibits 12-O-tetradecanoylphorbol-13-acetate-induced hydrogen peroxide 
production in human polymorphonuclear leukocytes and HL-60 cells [8, 9]. The antioxidant 
mechanism which genistein shows leads to an inhibition of the activation of NF-κB 
stimulated by oxidative stress and chemokine-8 secretion, via a decrease in either caspase-3 
or protein tyrosine kinase activity [10-13]. Thus, the ability of genistein to inhibit the 
generation of ROS, resulting in the inhibition of NF-κB activation, makes it a strong 
candidate as an antioxidant and a powerful chemopreventive agent.  
2.1.4 Genistein and immunity 
The effects of genistein in immunity are well studied among the isoflavones. In some 
studies, ovariectomized (OVX) mice were used to avoid the effect of endogenous estrogen. 
The results showed that the influence of genistein on OVX mice and on the non OVX 
model is different. Genistein induced dose-dependent reductions in thymic weight and size 
in OVX mice. It decreased thymocyte numbers by up to 86 % and reduced the number of 
peripheral lymphocytes and antigen-specific antibody titers [14, 15]. Treatment of genistein 
administered mice with anti-estrogen faslodex (ICI182780) partially restored thymic weight. 
Therefore, the effect of genistein could partly be related to interactions with the estrogen 
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receptor. Non-OVX mouse, daily feeded with 4-20 mg / kg genistein showed increases of 
non-specific immune functions in a dose-dependent manner. Also the production of IL-4 
and IFN-γ was increased and cytotoxic T cell and NK cell activity was enhanced [16-18]. 
Meanwhile, in vitro experiments found that relatively high doses of genistein can inhibit 
mitogen- and alloantigen-induced lymphocyte proliferation [19]. 
2.1.5 Genistein and inflammation 
Genistein possess anti-inflammatory properties as a result of different mechanisms 
(Tab. 2.2). It can inhibit phospholipase A2, cyclooxygenases, and lipooxygenases resulting 
in the reduction of levels of pro-inflammatory mediators. In vivo, genistein markedly 
attenuates ovalbumin-induced bronchoconstriction, pulmonary eosinophilia, and airway 
hyper-responsiveness in a guinea pig model of asthma. This anti-inflammatory effect may 
be mediated by the inhibition of the tyrosine kinase signalling cascade [20]. 
Intraperitoneally injected genistein was shown to protect rats from the endotoxin-induced 
organ failure [21], and later treatment with genistein reduced the degree of inflammation 
and joint destruction in collagen-induced arthritic mice. These therapeutic effects were 
mediated by a modulation of granulocytes, monocytes, and lymphocytes [22]. 
In vitro, genistein is able to suppress NO production in LPS activated murine 
macrophages in a dose-dependent manner by three mechanisms: scavenging of NO radicals, 
inhibition of inducible nitric oxid synthase (iNOS) enzyme activity, and inhibition of iNOS 
gene expression [22]. Genistein was shown to inhibit TNF-α production in LPS-induced 
RAW264.7 macrophages cells [23] and to inhibit IL-1β, IL-6, and TNF-α production from 
LPS-stimulated human blood monocytes [24]. The inhibitory effects of genistein on IL-6 
production have been shown in different cells: cultured human intestinal cells Caco2 [25], 
osteoblast cells [26], human gastric epithelial cells [27], or macrophages [28]. 
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Tab. 2.2 Anti-inflammatory mechanisms of genistein [29] 
 
2.1.6 Genistein and infection  
Genistein was reported to stimulate growth of C. albicans by increasing the rate of 
germination and enhancing Hsp90 expression. These biological effects may be attributable 
to genistein’s activity as a phytoestrogen [30]. Meanwhile, genistein strongly inhibited C. 
albicans yeast adhesion to Vitronectin and human endothelial cells by blocking the 
phosphorylation of endothelial cell proteins, therefore, it significantly reduced endocytosis 
of C. albicans due to inhibition of tyrosine kinase [31, 32].  
2.1.7 Genistein involved in signal transduction pathways 
Genistein modulates several key elements of signal transduction pathways related to 
cellular growth and survival. These cover the full spectrum of the intracellular signalling 
network.   
2.1.7.1 Inhibition of the activation of NF-κB   
The transcription factor NF-κB plays an important role in the control of cell growth, 
differentiation, apoptosis, and stress-response. Under non-stimulating conditions, NF-κB is 
Activity Mechanism Effect 
Antioxidant activity Radical scavenging  
Inhibition of ROS production  
Inhibition of pro-oxidant enzymes 
Lower the amounts of free 
radicals  
Inhibition of lipidic 
peroxidation  
Modulation of  
inflammatory cells 
Modulation of enzymatic activity 
Modulation of secretory processes 
Inhibition of inflammatory cells 
activation  
Modulation of  
proinflammatory enzymes 
Inhibition of arachidonic acid 
enzymes 
Inhibition of NO synthase 
Inhibition of the production of 
inflammatory mediators  
NO, leukotrienes, 
prostaglandins 
Modulation of  
proinflammatory mediators 
Modulation of cytokine 
production 
Inhibition of the inflammatory 
cytokines: TNF-a and 
interleukines 
Modulation of   
proinflammatory gene 
expression  
Modulation of signal transduction  Inhibition of proinflammatory 
gene transcription  
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sequestered in the cytoplasm through tight association with the impeding IκB proteins. 
Following stimulation, the IκB proteins are phosphorylated and degraded, allowing the 
NF-κB to translocate to the nucleus, bind to the NF-κB specific DNA binding sites or 
interact with other transcription factors, and thus regulate gene transcription. NF-κB plays a 
major role in pathways involved in inflammation and innate immune reponses [33]. 
Genistein blocks the activation of NF-κB concomitant with degradation of IκBα in 
human myeloid leukaemia cells [34]. Genistein inhibits the translocation of NF-κB to the 
nucleus, preventing NF-κB from binding to its target DNA and thereby inhibiting the 
transcription of NF-κB downstream genes. This process ultimately inhibits cell growth and 
also induces apoptotic cell death. Genistein has also been found to potentiate the antitumor 
activity of chemotherapeutic agents through regulation of NF-κB [35, 36] . 
2.1.7.2 Regulation of Akt signalling pathway  
Akt is a serine/threonine protein kinase that plays a key role in multiple cellular 
processes. Akt signalling is another important signal transduction pathway that plays a 
critical role in controlling the balance between cell survival and apoptosis [37]. Akt also 
regulates the NF-κB pathway via phosphorylation and activation of molecules in the NF-κB 
pathway [38, 39]. Genistein treatment reduces the level of the phosphorylation of the Akt 
protein compared to control cells, resulting in a dose-dependent induction of apoptosis of 
cells that display constitutively active Akt [40]. Genistein pre-treatment abrogated the 
activation of Akt by EGF-stimulated PC-3 prostate cancer cells [41], demonstrating that 
genistein inhibits the activation of Akt, which may result in the inhibition of survival 
signals ultimately leading to induction of apoptotic signals. Genistein exerts its inhibitory 
effects on NF-κB pathway through the Akt signalling pathway in cancer cells [25]. 
Genistein has been shown to exert inhibitory effect on Akt activation induced by estradiol 
in MCF-7 cells [42, 43]. Collectively, these results demonstrate that genistein exerts its 
inhibitory effect on NF-κB signalling through Akt pathway. Thus, abrogation of NF-κB and 
Akt signalling pathway by genistein may be one of the molecular mechanisms by which 
genistein inhibits inflammation and cancer cell growth, and induces apoptosis. 
2.1.7.3 Regulation of MAPK pathway  
Mitogen-activated protein kinases (MAPK) are a family of serine/threonine kinases, 
which connect inflammatory and other extracellular signals to intracellular responses. 
2  Introduction                                                                                  9                      
 
MAPK pathway consist of a module of three kinases where MAPKKK activates a MAPKK 
that activates a MAPK (ERK, JNK, and p38), resulting in the activation of transcription 
factors like AP-1. Activation of the MAPK pathways may cause the induction of phase II 
detoxifying enzymes and positively regulate the expression of a number of cytokines genes 
[44]. 
Genistein has been found to regulate the molecules in the MAPK pathway in different 
ways: Genistein is reported to inhibit TGF-β-mediated p38 MAP kinase activation and 
matrix metalloproteinase type 2 [45]. In other studies, genistein has been found to be 
effective in preventing cytokine-induced ERK-1/2 activation and promoted apoptotic cell 
death [46]. Since genistein is a well known inhibitor of tyrosine kinases, it is possible that 
genistein inhibits tyrosine kinases upstream of p38 and subsequently inhibit the 
phosphorylation of tyrosine residues on p38, leading to the inactivation of MAPK pathway. 
On the other hand, genistein also could potentiate the phosphorylation of p38, ERK1/2 in 
breast cancer lines [47-49].  
In summary, the modulation of a large number of signalling pathways is a distinctive 
property of genistein.  
2.2 Phagocytes in the immune system 
2.2.1 Immune system 
The immune system is a remarkable versatile defence system that has evolved to 
protect animals from invading pathogenic microorganisms and cancer. It comprises an 
enormous variety of cells and molecules capable of specifically recognizing and eliminating 
foreign invaders [50].  
The immune system has two principal components: innate and adaptive immunity, 
which work in concert to defend the body against infection. The innate immune system 
recognizes directly a wide variety of microorganisms through highly conserved receptors 
and essential microbial molecules, such as lipopolysaccharides present on the cell wall of 
gram-negative bacteria and lipoteichoic acids present in gram-positive bacteria. The cells of 
the innate immune system represent the first line of defence in the immunosurveillance 
network. In contrast to the broad reactivity of the innate immune system, the specific 
components of the adaptive immunity, such as lymphocytes and antibodies, recognize an 
antigenic challenge to the organism with a high specificity. Once the immune system has 
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recognized and responded to an antigen, it exhibits immunologic memory; a second 
encounter with the same antigen induces a faster and more efficient state of immune 
reactivity. Therefore, life-long immunity against many infectious agents can be acquired 
after an initial encounter.  
2.2.2 Phagocytes and their functions 
The most important effector cells of the innate immune system are bone 
marrow-derived cells that circulate in the blood and migrate into tissues [51]. These include 
cells of the myeloid lineage including neutrophils, mononuclear phagocytes, and dendritic 
cells (Tab. 2.3).  
Tab. 2.3  Phagocytes and their function in the innate immune system [52] 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
The mononuclear phagocyte system consists of cells that have a common lineage 
whose primary function is phagocytosis and which play central roles in innate and adaptive 
immunity. Monocytes, incompletely differentiated after leaving the marrow, are the first 
cells that enter the blood. Once they enter tissues, these cells mature and differentiate into 
macrophages. Macrophages are the first phagocytes to encounter invading microorganisms 
(Fig. 2.2). They are dispersed throughout the body; some take up residence in particular 
tissues, become fixed macrophages and are named specifically according to different 
Cell  Morphology Activated function 
Macrophage Phagocytosis and activation of 
bactericidal mechansims  
Dendritic cells Antigen uptake in peripheral 
sites 
Neutrophil 
 
Phagocytosis and activation of 
bactericidal mechansims 
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tissues. For example, in the central nervous system, they are called microglial cells, in the 
connective tissue histiocytes, in the lung they are called alveolar macrophages and in the 
liver Kupffer cells. Macrophages rapidly respond to microbes and survive much longer than 
neutropils at the sites of inflammation. They can undergo cell division at an inflammatory 
site. Therefore, macrophages are the dominant effector cells of the later stages of the innate 
immune response, 1 or 2 days after infection [53]. 
 
Fig. 2.2 Typical morphology of a monocyte and a macrophage. Macrophages are five to ten fold 
larger than monocytes and contain more organelles, especially lysosomes [50]  
2.2.3 Pattern recognition receptors 
Macrophages, neutrophils, and monocytes are the main cells of the host innate 
immune response that recognize invading pathogens. Monocytes express high levels of 
Toll-like receptors (TLRs) on their cell membranes, as well as moderate levels of lectin 
receptors (LRs). During differentiation into macrophages, they retain expression of TLRs 
while strongly upregulating their expression of LRs [54].  
Important differences in the expression of several receptors have also been reported 
between resident and inflammatory macrophages, as the expression of pattern recognition 
receptors (PRRs) can be modified by cytokines or microbial products. DCs, which are 
crucial for antigen processing and presentation, also express most of the PRRs that are 
important for the recognition of fungal pathogens. Several classes of PRRs such as dectin-1, 
Toll-like receptors (TLR), families of cytosolic proteins (e.g. NODs, NALPs), and retinoic 
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acid inducible gene (RIG)-I-like receptors (RLR) have been identified so far [55-57]. These 
PRRs recognize various pathogen-associated molecular patterns (PAMPs) [58] in a number 
of cell compartments, such as bacterial lipopolysaccharide or fungal β-glucans, and trigger 
the release of inflammatory cytokines and type I interferon for host defence [55, 59]. Here 
we briefly listed the receptors associated with C. albicans infections (Fig. 2.3-Fig. 2.4).  
 
Fig. 2.3 Pattern-recognition receptors on the surface of macrophage involved in C. albicans 
recognition[54]. CR3: complement receptor 3; FcγR: Fcγ receptor; MR: mannose receptor; TLR: 
Toll-like receptor. 
 
Fig. 2.4 Recognition of Candida albicans at the membrane level [54]. 
2.2.3.1 Toll-like receptors  
TLRs recognize various PAMPs derived from viruses, pathogenic bacteria, pathogenic 
fungi, and parasitic-protozoa. TLRs are expressed in distinct cellular compartments. TLR1, 
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TLR2, TLR4, TLR5, TLR6, and TLR11 (only expressed in mice) are expressed on the cell 
surface whereas TLR3, TLR7, TLR8, and TLR9 are expressed in intracellular vesicles such 
as the endosome and ER. The intracellular TLRs are transported to the intracellular vesicles 
via UNC93B1, a transmembrane protein, which is localized in the endoplasmatic reticulum 
of the cell [60-63]. All TLRs differ from each other in ligand specificities, expression 
patterns, and in the target genes which they can induce [58] (Tab.2.4). 
TLRs are type I integral membrane glycoproteins and have a trimodular structure. The 
extracellular N-terminal domain consists of approximately 16-28 leucine-rich repeats 
(LRRs) and each LRR consists of 20-30 amino acids with the conserved motif 
“LxxLxLxxN”. The intracellular C-terminal domain is known as the Toll/IL-1 receptor 
(TIR) domain, which shows homology with that of the IL-1 receptor [58, 59, 64, 65]. This 
domain is required for the interaction and recruitment of various adaptor molecules to 
activate the downstream signalling pathway (Fig. 2.5). 
Activation of signal transduction pathways downstream of TLRs leads to the induction 
of the expression of various genes that function in host defence, including inflammatory 
cytokines, chemokines, major histocompatibility complex (MHC), and co-stimulatory 
molecules. In this thesis, we were interested in the TLR4 signalling pathways. The TLR4 
signalling pathways are categorized into MyD88 (Myeloid differentiation primary response 
gene 88)-dependent and TRIF (TIR-domain-containing adapter-inducing 
interferon-β)-dependent pathways [67]. The MyD88-dependent pathway is utilized by all 
TLRs except TLR3. Stimulation with the TLR ligand recruits MyD88 and the IRAK family 
of protein kinases to the receptor, which leads to the activation of TRAF6. TRAF6 causes 
activation of TAK1 via K63-linked polyubiquitination, which results in activation of NF-κB 
and AP-1 through the IKK complex and MAP kinases, respectively (Fig. 2.5). TLR3 and 
TLR4 initiate a TRIF-dependent pathway to induce the expression of inflammatory 
cytokines and type I interferons. The TRIF-dependent pathway activates NF-κB via two 
independent pathways. The N-terminal domain of TRIF interacts with TRAF6 and activates 
NF-κB. The c-terminal domain of TRIF interacts with RIP1 and activates TAK1. The 
TRIF-dependent pathway also induces type I interferon through IRF3. IRF3 is 
phosphorylated and activated by IKK-related kinases, TBK1, and IKKi (IKKε). TRAF3 
acts as a linker between TRIF and TBK1 (Fig. 2.5).  
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Tab. 2.4  Description of TLRs 
TLR Location 
of TLR 
Ligand Target 
pathogen 
Signalling 
adaptor 
Transcription 
factor 
Cytokines 
induced 
TLR1/2 Cell 
surface 
Triacylated 
lipoproteins 
 
Bacterial and 
mycobacteria 
TIRAP,MyD
88 
NF-κB Inflammatory 
cytokines(TNF-α, 
IL-6 etc) 
TLR2 Cell 
surface 
Peptidoglycan
, lipoproteins, 
zymosan 
 
Gram-positive 
bacteria 
S. aureus, S. 
pneumoniae, 
yeast 
and other 
fungi 
TIRAP,MyD
88 
NF-κB Inflammatory 
cytokines(TNF-α, 
IL-6 etc) 
TLR3 Endosome Double 
stranded RNA 
(dsRNA) 
 
Viruses 
 
TRIF NF-κB, 
IRF3,7 
Inflammatory 
cytokines(TNF-α, 
IL-6 etc), type I 
IFNs 
TLR4 Cell 
surface 
LPS 
 
Gram-negative 
bacteria, 
 
MyD88 NF-κB, 
IRF3,7 
Inflammatory 
cytokines(TNF-α, 
IL-6 etc), type I 
IFNs 
TLR5 Cell 
surface 
Flagellin 
 
S. 
typhimurium, 
P. aeruginosa 
 
MyD88 NF-κB Inflammatory 
cytokines(TNF-α, 
IL-6 etc),  
TLR6/2 Cell 
surface 
Diacylated 
lipoproteins, 
zymosan 
 
Mycobacteria, 
yeast and 
fungi 
 
TIRAP,MyD
88 
NF-κB Inflammatory 
cytokines(TNF-α, 
IL-6 etc),  
TLR7/8 Endosome Single-strande
d RNA 
(ssRNA) 
 
Viruses, HIV, 
Denge virus 
influenza 
 
MyD88 NF-κB,IRF 7 Inflammatory 
cytokines(TNF-α, 
IL-6 etc), type I 
IFNs 
TLR9 Endosome CpG DNA 
 
Bacterial 
DNA 
 
MyD88 NF-κB,IRF 7 Inflammatory 
cytokines(TNF-α, 
IL-6 etc), type I 
IFNs 
TLR10 Unknown 
 
Unknown 
 
Unknown 
 
Unknown 
 
Unknown 
 
Unknown 
 
TLR11 Cell 
surface 
Profilin, 
uropathogenic 
bacteria 
 
T. gondii 
Uropathogenic 
bacteria 
 
MyD88 NF-κB Inflammatory 
cytokines(TNF-α, 
IL-6 etc), 
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Fig. 2.5 TLR signalling in conventional dendritic cells, macrophages and plasmatoid dendritic cells [66]. 
2.2.3.2 Dectin-1 receptor 
Dectin-1 is a type II transmembrane protein receptor that belongs to the c-type lectin 
family of receptors, containing an extracellular c-terminal c-type lectin domain, a short 
stalk region, a single transmembrane domain, and a short 40 amino acid aminoterminal 
intracellular tail which contains an ITAM (immunoreceptor tyrosine-based activation-like 
motif) [68]. Dectin-1 can mediate various protective responses through Syk-CARD9 
(spleen tyrosine kinases and caspase recruitment domain protein 9)-dependent pathways, 
such as the stimulation of IL-2, IL-10 [69], and IL-6 [70].  
There are two major isoforms of dectin-1, one encoding the full length receptor and a 
version which lacks the stalk [71]. Murine dectin-1 is widely expressed by many cell types, 
including macrophages, dendritic cells, monocytes, neutrophils, and a subset of splenic T 
cells [72]. The expression of human dectin-1 is also found in B cells, eosinophils, and mast 
cells [73, 74]. Murine dectin-1 expression can be influenced by various cytokines and 
microbial factors. IL-4, IL-13, and GM-CSF cause a highly up-regulated dectin-1 
expression. In contrast, IL-10, LPS, and dexamethasone cause down-regulation of dectin-1 
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expression [75].  
Dectin-1 was initially identified as a dendritic-cell-specific receptor that modulates T 
cell function through recognition of an unidentified ligand [68, 76]. It was subsequently 
reidentified as a receptor for β-glucans [77, 78]. Due to its β-glucan specificity, dectin-1 
recognizes a number of fungal species, including C. albicans, P. carinii, S. cerevisiae, 
Coccidioide sposadasii, and Aspergillus fumigatus [78-83]. The ligation of dectin-1 also 
triggers intracellular signalling resulting in a variety of cellular responses, including 
phagocytosis. Apart from Syk-dependent signalling from dectin 1, dectin 1 also 
collaborates with the TLR2 receptor to stimulate the MAPK (mitogen-activated protein 
kinase) and NF-κB (nuclear factor-κB) pathways, with subsequent production of 
pro-inflammatory cytokines such as TNF (tumour necrosis factor) [78, 84]. 
2.2.3.3 Mannose receptor 
The mannan receptor was the first receptor found on the surface of macrophages. It is 
a c‑type lectin mannose receptor (MR) [85, 86], which recognizes oligosaccharides that 
terminate in mannose, fucose, and N-Acetylglucosamine (GlcNAc) [87]. This binding is 
mediated by 4 to 8 carbohydrate-recognition domains (CRDs) in the extracellular region of 
the receptor [88]. MR preferentially recognizes α-linked oligomannoses with branched, 
rather than linear, structures from C. albicans in monocytes and macrophages [89, 90], 
resulting in important protective effects against C. albicans infections such as stimulation 
of cytokine production, induction of DC maturation, and T cell immunity [54].  
2.2.3.4 Interferon gamma receptor 
Interferon γ (IFN γ) is released in an immune response by T lymphocytes and natural 
killer (NK) cells and plays an important role in the host defense against virus and 
mycobacteria [91]. The receptor for IFN γ is expressed on lymphoid cells, including 
monocytes, macrophages, T cells, B cells, NK cells, and nonlymphoid cells such as 
fibroblasts and endothelial cells [92]. IFN γ acts on macrophages to increase ability to resist 
the growth of intracellular pathogens by enhancing production of antimicrobial effector 
molecules, such as reactive oxygen species (ROS) and nitric oxide (NO) [93, 94]. The 
receptor complex consists of the heterodimer of two chains: IFNGR1 and IFNGR2a. 
Binding of IFN γ to the receptor activates the Jak2-Stat1 signaling pathway [95, 96]. The 
receptor-associated Jak1 and Jak2 tyrosine kinases phosphorylate the IFNGR-1 chain. The 
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tyrosine-phosphorylated receptor recruits signal transducer and activator of transcription 1 
(Stat1) to the receptor, resulting in the tyrosine phosphorylation of Stat1. The 
phosphorylated Stat1 forms dimers and translocates to the nucleus and, after binding to a 
specific sequence in the promoter region of IFN-γ-inducible genes, induces gene 
transcription. 
2.2.4 Specific kinases involved in pathways activated by LPS 
and IFN-γ  
Kinases and phosphatases play an important role in signal transduction casacades 
activated by LPS and IFN-γ in macrophages (Fig. 2.6). Already in 1991, LPS was reported 
to induce tyrosine phosphorylation of several proteins, and two of these tyrosine 
phosphoproteins of 41 and 44 kDa are isoforms of mitogen-activated protein (MAP) kinase 
[97-99]. Tyrosine kinase Jak2 was also reported to be involved in LPS-induced macrophage 
activation by regulating the PI3 kinase and the MAP kinase JNK which controls the 
expression of inflammatory factors affecting the release of IL-1β [100]. Meanwhile, LPS 
can activate the human monocyte PI3K pathway [101, 102]. The tyrosine kinase Syk plays 
an important role in the activation cascade in rat alveolar and peritoneal macrophages in 
vitro, and in the human THP-1 cell line [103]. Src tyrosine kinase inhibitor PP1 was found 
to inhibit LPS-induced macrophage activation, iNOS expression, and TNF-α production 
[104, 105].  
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Fig. 2.6 Scheme of kinase involved in the LPS and IFN-γ activated macrophage signaling pathways 
according to the literature. Black arrows show the known connection, dash arrows mean that the 
mechanism is not clear yet.  
 
2.2.5 Phagocytosis  
Phagocytosis is the process of internalization of particles by cells: in the first step in 
phagocytosis, macrophages are attracted by and move toward a variety of substances 
generated in an immune response; this process is called chemotaxis. The next step in 
phagocytosis is adherence of the antigen to the macrophage cell membrane. Complex 
antigens, such as whole microbial cells or viral particles, tend to adhere well and are readily 
phagocytosed; isolated proteins and encapsulated bacteria tend to adhere poorly and are less 
readily phagocytosed. Adherence induces membrane protrusions in the mammalian cells 
called pseudopodia, which extend around the attach materials. Fusion of the pseudopodia 
encloses the material within a membrane-bound structure called phagosome and then enters 
the endocytic processing pathway. In this pathway, the phagosome moves toward the cell 
interior, where it fuses with a lysosome to form a phagolysosome. Lysosomes contain 
lysozyme and a variety of other hydrolytic enzymes that digest the ingested material. The 
digested contents of the phagolysosome are then eliminated in a process called exocytosis.  
2  Introduction                                                                                  19                      
 
The macrophage membrane has receptors for certain classes of antibodies. If an 
antigen is coated with the appropriate antibody, the complex of antigen and antibody binds 
to antibody receptors on the macrophage membrane more readily than antigen alone and 
phagocytosis is enhanced [50].  
2.2.6 Killing of phagocytosed microbes 
Activated macrophages kill phagocytosed microbes by the action of microbicidal 
molecules in phagolysosomes: activated macrophages produce several proteolytic enzymes 
in the phagolysosomes, which function to destroy microbes. Moreover, reactive oxygen 
species are produced which are highly reactive oxidizing agents that destroy microbes. In 
addition to reactive oxygen species, macrophages produce reactive nitrogen intermediates, 
mainly nitric oxide (NO), by the action of an enzyme called inducible nitric oxide synthase 
(iNOS). However, when macrophages are strongly activated, they can injure normal host 
tissues by the release of lysosomal enzymes ROS and NO. The microbicidal products of 
these cells do not distinguish between self tissue and microbes. As a result, if these products 
enter the extracellular environment, they are capable of causing host tissue injury [50].  
2.3 Candida albicans 
2.3.1 Background 
C. albicans is a polymorphic fungus from the Ascomycota, diverged from S. 
cerevisiae around 200 million years ago [106, 107]. C. albicans is able to grow in a variety 
of morphological forms. These range from unicellular budding yeast (Fig. 2.7 A) to hyphae 
(Fig. 2.7 C) [106, 108]. In between these two morpholgy, the fungus can form 
pseudohyphae. Pseudohyphae resemble hyphae, but are morphologically different. Hyphae 
and pseduhyphae are both important virulence factors. Hyphae formation can be triggered 
by specific environmental conditions, such as temperature of 37 °C, neutral or alkaline pHs, 
increased CO2 concentrations, or the presence of serum [107] (Fig. 2.7). C. albicans also 
expresses several other virulence factors that contribute to pathogenesis. These factors 
include adhesions, secreted aspartyl proteases, and phospholipases [109].  
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Fig. 2.7 Yeast, hyphal and pseudohyphal morphologies [107] (A) budding yeast (B) pseudohyphae 
(C) hyphae 
 
C. albicans is a ubiquitous fungal organism that often colonizes the skin and the 
mucosal surfaces of healthy individuals without causing disease. However, when the 
normal host defence mechanisms are impaired (for example, in patients who are undergoing 
chemotherapy for malignancies, receiving immunosuppressants after an organ transplantion, 
or patients with AIDS), C. albicans can become a pathogen. Candidaemia has an incidence 
of between 1.1 and 24 cases per 100,000 individuals and an associated mortality rate of 
more than 30 % [110, 111].  
Currently, several classes of systemic antifungal compounds are applied in the clinical 
practice. They target pathways related to the structure and synthesis of the fungal cell 
membrane or cell wall. Fluconazole and other azoles lead to the depletion of ergosterol, an 
essential component of the cell membrane; amphotericin B interacts with sterols in the 
outer cell membrane, leading to changes in permeability and leakage of cytosolic 
components; and echinocandins inhibit synthesis of β-glucans of fungal cell walls. The 
application of these antimycotic agents are challenged by the increasing numbers of 
resistant strains and severe side effects [112]. Therefore, there are desperate needs for new 
therapeutics addressing new targets.  
2.3.2 The MAP kinases signal transduction network in C. 
albicans 
MAP (mitogen-activated protein) kinases signal transduction pathways are widespread 
in eukaryotic cells to couple environmental responses to transcriptional regulation. The core 
structure of MAPK pathway is highly conserved, they comprise three kinases: the MAP 
kinase (MAPK), the MAP kinase kinase (MAPKK), and the MAP kinase kinase kinase 
(MAPKKK). When the MAPKKK is activated by upstream signals, it becomes 
phoshorylated and in turn phosphorylates the MAPKK which, in turn, does so to the MAPK. 
The MAPK usually transmits the signal to downstream transcription factors that generate a 
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specific adaptive response. These pathways have been extensively characterized in the 
non-pathogenic model yeast species S.cerevisiae and Schizosaccharomyces pombe. In S. 
cerevisiae they are involved in several different processes, such as adaptation to high 
osmolarity (HOG pathway), mating, growth, and cell integrity (PKC1-mediated pathway) 
(Fig. 2.8). Proteins homologous to the S. cerevisiae MAPK have been identified in C. 
albicans and are designated Cek1p, Hog1p, Mkc1p, Cek2p, and Csk1p, respectively. 
 
Fig. 2.8 HOG and Cek1 mitogen-activated protein kinases signalling in C. albicans [113]. 
2.3.2.1 The HOG pathway 
The HOG pathway in C. albicans is implicated in several stress resistance mechanisms 
(osmotic, oxidative, temperature, and antifungal drugs), such as regulation of cell wall 
biosynthesis (adherence to host cells), white-opaque switching, morphogenesis, and 
virulence of the organism [114]. 
In C. albicans, this pathway is activated by the plasma membrane protein CaSln1p, a 
sensor histidine kinase forming a two-component system with Ypd1p. Another two 
cytoplasmic histidine kinases, Chk1p [115] and CaNik1p [116], are also involved in 
osmosensing, morphogenesis, and cell wall biogenesis [114]. Under non-stress conditions, 
Sln1p phosphorylates itself, which leads to the constitutive activation of CaSln1p and 
Ypd1p. The phosphate is then transferred to CaSsk1p, which inhibits the activation of 
Ssk2p and CaSsk22p. Under hyperosmotic stress inducing conditions, the initial step of 
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phosphorylation in the cascade is inhibited, allowing phosphorylation of Ssk2p and 
CaSsk22p and hence the activation of the MAPK pathway through Pbs2p and Hog1p. 
Phosphorylation of Hog1p can activate the transcriptional activators Hot1p, Msn2p, Msn4p, 
and Skn7p, or the repressor Sko1p [117]. Deletion mutants of CaHOG1 are sensitive to 
osmotic stress and resistant to compounds (nikkomycin Z, Congo red, and calcofluor white) 
that interfere with cell wall function. CaHOG1 also has a repressive effect on pseudohyphal 
and filamentous growth. Deletion of CaHOG1 also results in a drastic decrease in mortality 
in systemically infected mice, suggesting a role for this MAP kinase pathway for the 
virulence of C. albicans [118].  
2.3.2.2 The Cek1-mediated pathway 
The Cek1p MAPK pathway was first studied in 1992 by Whiteway et al. and is known 
in C. albicans for its role in growth [119], mating [120], and cell wall construction [121]. 
This pathway is activated by the small GTPase Cst20p, subsequently acting upon the 
MAPKKK Ste11p followed by Hst7p, Cek1p, and finishing with the activation of the 
transcription factor Cph1p (Fig. 2.8). Disruption of CEK1 causes defects in switching from 
unicellular budding growth to invasive hyphal growth on certain media, such as Lee’s or 
Spider medium. CEK1 gene codes for a virulence determinant of C. albicans both in 
systemic murine candidiasis and localized murine candidiasis [119] [122]. 
2.3.3 Cell wall structure 
The fungal cell wall is an essential organelle that maintains the viability of fungal cells. 
Knowledge of the structure of the cell wall is necessary to understand how it is recognized 
by the host immune system. Fungal cell walls combine skeletal and matrix components. 
The skeletal component of the cell wall of C. albicans is a core structure of β-(1,3)-glucan 
covalently linked to β-(1,6)-glucan and chitin (αβ-(1,4)-linked polymer of 
N-acetylglucosamine (GlcNAc))(Fig. 2.9). These polymers form hydrogen bonds between 
adjacent polysaccharide chains to form a tough three-dimensional network of microfibrils. 
The skeletal components of the cell wall are always found close to the cell membrane in an 
inner layer, although some chitin and glucan can be present throughout the whole wall. In 
budding yeast cells, chitin and β-(1,3)-glucan can become exposed at the surface of 
budding scar [123]. In addition to the glucan and chitin skeleton, the C. albicans cell wall 
contains a matrix that mainly comprises glycosylated proteins. The major class of cell wall 
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proteins are glycosylphosphatidylinositol (GPI)-anchor-dependent cell wall proteins 
(GPI-CWPs), which are attached through a GPI remnant to β-(1,3)-glucan or chitin by a 
highly branched β-(1,6)-glucan linker. The CWPs are normally highly glycosylated with 
mannose-containing polysaccharides (sometimes called mannan), and carbohydrates can 
account for up to 90% of their molecular mass. Many CWPs have a lollipop structure with a 
globular domain that is presented to the outside of the cell and a Ser/Thr-rich polypeptide 
stem-like domain that is stabilized in the cell wall by O-linked mannan side chains. These 
ether-linked O-mannans are relatively short linear polysaccharides that consist of one to 
five mannose (Man) sugars, that are almost exclusively α-(1,2)-linked (Fig. 2.9). N‑mannan 
consists of a core Man8GlcNAc2 triantennary complex to which a highly branched structure 
is attached, comprising up to 150 mannose sugars arranged as an α-(1,6)-linked backbone 
with side chains of α-(1,2)-, α-(1,3)-mannose and phosphomannan (Fig. 2.9).  
 
Fig. 2.9 The structure of the C. albicans cell wall[54]. Cwp stands for cell wall protein. 
 
2.3.4 Respiratory chain  
Mitochondria are known as the power houses of the cell, they play very important 
roles in a range of processes such as ATP production, electron transport, and oxidative 
phosphorylation, release of caspase-activating proteins, generation of reactive oxygen 
species (ROS) and changes of cellular redox potentials [124]. Due to these properties, 
mitochondria are considered to be a potential target for antifungal agents. Compounds such 
as rotenone, antimycin, myxothiazols, melithiazols and cystothiazoles are known to exert 
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their antifungal activity by specifically inhibiting the electron transport within the 
respiratory chain [125, 126]..  
The complex structure of the respiratory chain in C. albicans is not yet fully elucidated. 
As in mammalian cells, the conventional respiratory chain of C. albicans comprises four 
large respiratory chain enzyme complexes (Fig. 2.10): NADH–ubiquinone oxidoreductase 
(complex I), succinate dehydrogenase (complex II), ubiquinol–cytochrome c (cytochromes 
bc1, complex III), and cytochrome c oxidase which is the terminal oxidase (cytochrome aa3, 
complex IV). In each complex, electron transport is coupled to proton translocation, with 
the resultant proton motive force being used for ATP synthesis. Specific inhibitors are 
known for each complex: rotenone inhibits complex I, TTFA inhibits complex II, antimycin 
A and myxothiazol inhibit complex III, and cyanide inhibits complex IV. This conventional 
respiratory chain provides a conserved route for passaging of electrons from NADH to 
molecular oxygen.  
 
Fig. 2.10 Structure of respiratory chain of C. albicans [127] 
 
 Additional NADH dehydrogenases (internal and external, facing the mitochondrial 
matrix and intermembrane space) act in parallel with complex I [128]. These 
dehydrogenases do not translocate protons [129] and are only partially sensitive to rotenone. 
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In addition, C. albicans, in common with many other fungal species, expresses an 
alternative oxidase (AOX) that branches off at the level of coenzyme Q (CoQ) in response 
to changing environmental conditions or cellular energy demands [130, 131]. It is induced 
by treatment with inhibitors of complex III and IV, such as antimycin A or cyanide [132].  
Also in S. cerevisiae, elements of the conserved respiratory chain are present, but the 
complex I is absent [133]. Instead, S. cerevisiae has three NADH dehydrogenases 
associated with the inner mitochondrial membrane capable of coupling the oxidation of 
NADH to the reduction of CoQ [134-136] (Fig. 2.11). One internal NADH dehydrogenase 
(NDI) faces the matrix space and utilizes mitochondrial NADH; the other two external 
NADH dehydrogenases face outward and can receive electrons from cytosolic NADH 
(NDE1 and NDE2). 
 
Fig. 2.11 Structure of respiratory chain of S. cerevisiae 
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2.4 Thesis aim and objectives  
The aim of the thesis is to investigate the role of genistein in C. albicans infections. 
The activity of genistein was examined using a murine macrophage cell line in vitro. The 
design of the experiments is outlined in Fig. 2.12. 
Experiments were designed to investigate the following specific objectives: 
 
 To identify potentential effects of genistein on the properties of the immune cells 
including (i) anti-inflammatory effects of genistein and (ii) elucidation of the 
underlying mechanism 
 To determine the molecular effects of genistein on the pathogen C. albicans 
focusing on the modulation of the function of mitochondria of C. albicans 
 To examine the effects of genistein on the interaction of macrophages and C. 
albicans  
 To examine the role of single genes on the interaction of macrophages and C. 
albicans by using deletion mutants and identify the action of genistein on the 
mutants. 
Previous investigations have demonstrated that genistein shows a variety of biological 
activities. For example, genistein can function as a phytoestrogen, an antioxidant, and an 
inhibitor of a broad range of tyrosine kinases. Those lead to its chemoprotectant activities 
against different types of cancers, protection of cardiovascular disease, chronic 
inflammatory disorders, and antiviral properties. As C. albicans is an opportunistic 
pathogen, the immune situation plays a vital role for the protection against C. albicans 
infections. An impaired immune system increases the risks to acquire opportunistic 
infections and uncontrolled neoplastic tissue growth; while an over-activated immune 
system could lead to inflammation, allergy, and autoimmunity. Therefore, we first 
investigated the effects of genistein on immune cells represented by the macrophages cell 
line RAW264.7. We tested the effects of genistein on macrophages including effects on cell 
proliferation, cell morphology, cell cycle, cell skeleton structure, and anti-inflammatory 
effects against different stimuli from bacteria and cytokines. In order to determine the 
mechanisms, we utilized a reporter cell line (RAW- BlueTM cells) that was stably transfected 
to express a secreted embryonic alkaline phosphatase (SEAP) gene inducible by NF-κB and 
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AP-1 transcription factors. Quantitative real time PCR arrays and western blotting were 
used to further validate the alteration in gene expression and to investigate the 
phosphorylation of certain proteins (Fig. 2.12, Section 5.1 and 5.2).  
The investigations of the action of genistein on C. albicans focused on the 
mitochondria function. Oxygen uptake and the measurement of reactive oxygen species 
production were examined and compared with the action of specific respiration chain 
inhibitor in both organisms C. albicans and S. cerevisiae. The metabolic activity of C. 
albicans after genistein treatment was also determined by enzymatic assay (Fig. 2.12, 
section 5.3).   
The effects of genistein against C. albicans infection were determined in two ways. On 
one hand, genistein-pretreated macrophages were infected with C. albicans. On the other 
hand, macrophages were infected with C. albicans which were treated with genistein. 
Phagocytic efficiency and cytokine production were detected. The mechanisms were 
investigated in both infective conditions. Cell wall components analysis and cell surface 
hydrophobicity were further detected to elucidate the mechanisms.  
The MAP kinase pathways are related to cell wall integrity and regarded as important 
virulence factors regulator for C. albicans. We investigated the influence of single MAP 
kinase pathway gene deletions of C. albicans on the cell wall components structure and the 
phagocytic efficiency by macrophages. We further investigated the genistein effects on 
phagocytosis of the mutants to further elucidate the activity of genistein against C. albicans 
infection (Fig. 2.12, section 5.4).   
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2.5 Experimental design 
 
Fig. 2.12 Flowchart outlining overall design of experiments undertaken in the thesis: Words in 
purple color represent the methods used. Part 1 shows experiments designed for investigation the 
influence of pre-treated macrophage with genistein. Part 2 points out experiments designed for 
investigation of the influence of pre-treated C. albicans with genistein. Part 3 shows the interaction 
between genistein-treated macrophage with C. albicans as well as the interaction between 
genistein-treated C. albicans with macrophages 
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3  MATERIALS AND METHODS 
3.1 Equipment and materials 
Analyse balance PC4400, Mettler Sartorius 
CO2 Incubator CO2-Auto-Zero, Heraeus 
Bunsen burner Fireboy, Heraeus 
Steam sterilizer 464, Sauter GTA40, Biomedis 
Flow cytometry & Software FACS Canto & FACS Diva 5.0, BD Bioscience 
Flow cytometry & Software FACS Canto & FACS Diva 5.0, BD Bioscience 
Fluorescence microscope Kenyence 
Culture shaker Pilot-Shake, Kühner 
Magnet mixer MR 2002, Heidolph 
Multi-well-Fluorimeter  CytoFluor® Series 4000, PerSeptive Biosystems 
Synergy 4® BioTek 
pH meter pH 211 Microprocessor pH Meter, Hanna 
Instruments 
Pipettes Research 0.1-2.5 µl 1520615,  
Research 2-20 µl 3478105,  
Research 20-200 µl 3612935,  
Research 100-1000 µl 3633985,  
Research Multichannel 10-100 µl 3263575,  
Research Multichannel 30-300 µl 3582685, 
Eppendorf  
Transferpette® -8 10-100 µl 01F72011,  
Transferpette® -12 15-300 µl 03D5931, Brand 
Pipettinghelper Easypet® 4412, Eppendorf CellMate II, Matrix 
Plateshaker Titramax 1000, Heidolph 
Shaker Heidolph Innova 2100, New Brunswick 
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Scientific 
Microtiter plate reader & 
Software  
µQuant & KCjunior Installation, BioTek 
Instruments 
Sterile bench HLB 2448 & HBB2472 S, Heraeus 
Hera Safe, Therma Electron Corp. 
Thermomixer 5437, Eppendorf 
Oven Memmert 
Vortexer Vortex Genie 2, Scientific Industries 
VF2, IKA®-Labortechnik 
Water system MilliQ Water Purification Systems, Millipore 
Water bath Köttermann 
Hemocytometer Neubauer improved, Assistent Germany 
Centrifuge 5804R & 5402, Eppendorf  
Sepatech Megafuge1.0 & Biofuge fresco, 
Heraeus 
ELISA washer BioTek 
Needles TSK-SUPRA 1.1x100, Luer 
Combitips 
10 ml 1=0.2 ml 12307 & 500 µl 1=10 µl 360407, 
Eppendorf 
Single-use pipette 
Costar Stipette 5 ml 4487, 10 ml 4488 & 25 ml 
4489, Corning 
Cryovials 
Nalgene® Cryoware™ 5000-0020, Nalge Nunc 
Int. 
Multi-well-culture plate 
4 Well Nunclon Surface 176740, Nunc 
96 Well Tissue Culture Plate Flat Bottom 
353916, BD Falcon 
Pipette Tips 
epT.I.P.S. Standard 2-200 µl 0030000.870,  
epT.I.P.S. Standard 50-1000 µl 0030000.919, 
Eppendorf 
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Reaction tube Safe-Lock Tubes 1.5ml 0030120.86, Eppendorf 
Resevior 60 ml solution volume with cover, Eppendorf 
Cell culture flask 
Corning® Flask 0.2 µM Vent Cap Angled Neck: 
175 cm2 431080 & 75 cm2 430641, Corning 
Tissue Culture Flask 25 cm2 PS red filter cap 
690175, Greiner Bio-one 
Cell scraper 23 cm 179693 & 32 cm 179707, Nalge Nunc 
Centrifuge tubes 15 ml volume AN77.1 Roth 
50 ml volume 430291 & 430921, Corning 
Oxoplate® Presens, Regensburg  
3.2 Methods 
3.2.1 Sterile Conditions 
All work with yeasts and phagocytic cells were conducted under sterile conditions. 
Glassware (shaker flask, glass pipettes, etc.) were sterilized at 180 °C for six hours. Solutions, 
media and plastic materials (eg. pipette tips) were steam sterilized at 121 °C for 20 min; 
alternatively, solutions that were not suitable for steam sterilization were sterilized with a filter 
pore size of 0.2 microns (Millipore). All ready to use media and materials were purchased sterile 
from manufacturer. 
3.2.2 Preparing PBS 
The buffered, isotonic saline PBS (phosphate buffered saline) from tablets of Invitrogen 
(18912-014), was prepared according to manufacturers instructions: one pill (5 g) is solved in 500 
ml MilliQ-water, and adjusted to pH=7.4 with hydrochloric acid (HCl). 
3.2.3 Cell number counting 
The determination of the number of yeast and macrophages cells was carried out by using a 
Neubauer improved Hemocytometer (Fig. 3.1). It consists of nine large squares, each with an area 
of 1 mm2. Largest square in the center is divided into 5 × 5 small squares (each 0.04 mm2), which 
in turn consists of 4 × 4 midget squares (each 0.0025 mm2). The chamber depth is 0.1 mm. For 
the cell counting, the chamber was filled with 10 µl well mixed cell suspension and the cells were 
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counted under the microscope. The macrophages were counted within the four corner squares 
(big red square); cells which were located on the outer boundary lines were not been included. 
Subsequently, cell number was divided by four in order to obtain the mean value for each corner 
squares. The volume per corner square of a chamber is 0.1 µl, so this average was multiplied by 
1×104 in order to determine the number of cells per milliliter. For the determination of the 
concentration of yeast, cells were counted for five small squares (small red square) within the 
central large squares. The amount corresponded to the number of cells per 0.02 µl cell suspension, 
so this number was multiplied by 5×104 to identify the yeast concentration per milliliter. To avoid 
too high cell density, the counting was carried out by dilution of the cell suspensions in PBS and 
the dilution factor was included in the calculation of cell number. 
 
Fig. 3.1  Scheme of Neubauer improved Hemocytometer [137] 
3.2.4 Data analysis and Programmes 
The text, graphics and tables of this work were created with the programes Microsoft® office 
2007 (Microsoft Corp.) and OriginPro70 (Origin Lab Corp.). Significance of the data was 
evaluated using the student’s t-test.  
3.3 Cell culture 
3.3.1 Cell culture media and ingredients 
In Tab. 3.1，the cell culture medium and ingredients are listed. The DME medium was stored 
at 4 °C. 5 ml Pen-Strep solution and 50 ml FBS were added to 500 ml of DME medium before 
use. For RAW-BlueTM cells, 200 µg/ml ZeocinTM was additionally added to the prepared DMEM, 
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FBS was previously heat treated at 55 °C for 30 min. The media were warmed in a water bath at 
37 °C before use. The freezing medium was purchased and stored in 5 ml aliquots at -20 °C. 
Tab. 3.1 Cell culture medium and components 
 
 Company  Article number 
DMEM 
 (Dulbecco’s modification of Eagle’s medium) 
Lonza BE12-741F 
Frozen medium (with DMSO) Invitrogen 12648-010 
FBS (fetal bovine serum) Lonza 14-801F 
100x Pen-Strep (Penicillin-Streptomycin) Sigma P0781 
ZeocinTM Invivogen ant-zn-5b 
 
3.3.2 RAW264.7 
RAW264.7 cells are murine macrophages [138]. The cell line was purchased from the 
American Type Culture Collection (ATCC; TIB-71) and was cultivated immediately as indicated 
by ATCC after delivery. 
3.3.3 RAW-Blue™ 
RAW-Blue™ cells (InvivoGen; #raw-sp), derived from murine macrophages, are designed 
for the study of pattern recognition receptors (PRRs). They express a large repertoire of different 
classes of PRRs, such as the Toll-like receptors (TLRs), RIG-I-like receptors (RLRs) and 
NOD-like receptors (NLRs).  
They stably express a secreted embryonic alkaline phosphatase (SEAP) gene inducible by 
NF-κB and AP-1 transcription factors. RAW-Blue™ cells are resistant to the selection marker 
Zeocin™. Upon TLR, RLR or NOD stimulation, RAW-Blue™ cells activate NF-κB and/or AP-1 
leading to the secretion of SEAP which is easily detectable and measurable when using 
QUANTI-Blue™ as substrate. 
3.3.4 Cultivation 
The adherent RAW264.7 cells were grown in tissue culture flasks at 37 °C and 10 % CO2. 
The volume of DMEM was different by the size of the culture flask (Tab. 3.2). After reaching a 
confluence of approximately 80 %, the cells were harvested and passaged by scraping with a cell 
scraper and mixing the cells by repeated pipetting up and down with a glass pipette. Finally, an 
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aliquot (5-10 %) of the culture volume was transferred into a new culture flask and again grown 
to confluence.  
The cultivation of RAW-Blue™ cells is done in the same way as RAW264.7 cells. 
Tab. 3.2  Culture volume of different tissue culture flasks 
 
Surface of the bottle [cm2] Volume [ml] 
25 10 
75 30 
175 50 
 
3.3.5 Long-term storage 
80 % of confluent cells in a 25 cm2 culture flask were washed with 10 ml PBS, scraped, 
transferred into a 15 ml centrifuge tube and harvested by centrifugation (3000 rpm, 5 min, 4 °C). 
Subsequently, the supernatant was decanted; the cell pellet was resuspended in 1 ml of ice cold 
freezing medium and transferred into cryogenic vials. The cells were stored for 24 hours at 
-80 °C before they are permanently stored in liquid nitrogen at -196 °C. To reactivate, the cells 
were thawed as quickly as possible at 37 °C, and transferred into a 25 cm2 culture flask with   
10 ml DMEM medium to dilute the DMSO in the freezing medium. Once the cells had attached 
the bottom, the medium was changed to the complete removal of DMSO and the cells were 
cultured as described in (3.3.2). 
3.3.6 WST-1 toxicity assay   
The determination of cell vitality after a compound treatment was conducted using a 
tetrazolium salt, which is a redox indicator. In metabolically active cells, the tetrazolium ion is 
reduced by the dehydrogenases of the respiratory chain to formazan (Fig. 3.2). The formation of 
formazan results in a color change and can be detected and quantified by measuring the 
absorbance at the respective wavelength. In our work, the water soluble tetrasolium salt WST-1 
(4-[3-(4-Jodophenyl)-2-(4-nitrophenyl)-2H-5-Tetrazolio]-1.3-Benzoldisulfonate) from Roche 
Diagnostics (11644807001), was used. The reduction of WST-1 results in a water-soluble yellow 
product, which can be quantified at the wavelength of 450 nm. 
100 µl of RAW264.7 cells were seeded into 96-well cell culture plates at 2×106 cells / mL, 
1×106 cells / ml and 5×105 cells / ml in DMEM containing various concentrations of genistein 
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(Sigma: G6649). The cells were incubated for 2 h, 24 h and 48 h under normal cell culture 
condition. Subsequently, 10 µl WST-1 per well were added and the plate was placed on a plate 
shaker for 1 min to ensure optimal mixing. After 30 min incubation at 37 °C and 10 % CO2, the 
plate was analysed in a microtiter plate reader. For data analysis the mean value and standard 
deviation were determined from 8 replicates.  
 
Fig. 3.2: Principle of the toxicity tests cleavage of the tetrazolium salt WST-1 to formazan. (EC = electron 
coupling reagent RS = mitochondrial succinate-tetrazolium-reductase system) (Invitrogen) 
3.3.7 Cell cycle analyses  
The distribution of cells at the different stages in the cell cycle was estimated by flow 
cytometric DNA analysis. Propidium iodide is a fluorescence dye which can bind directly to the 
DNA in the nucleus, hence the measurement of the fluorescence provides a measure of the 
amount of dye taken up by the cell and indirectly the amount of DNA content. Cells were 
harvested and counted when the cells are up to approximately 80 % of confluence, 5×105 cells / 
ml were incubated for 24 h and 48 h with or without various concentrations of genistein. Cells 
from the different conditions were harvested and washed in the cold phosphate-buffered saline 
(PBS) pH=7.4, fixed in 70 % cold ethanol and stored at 4 °C until processing. The fixed cells 
were washed with cold PBS twice, then treated with flurochrome DNA staining solution (0.5 ml) 
containing propidium iodide (Sigma: P4170) (20 µg / ml) and RNase A (1 mg / ml) (Carl-Roth: 
2326466) for 1 hour, than the stained cells were analyzed by flow cytometry. The percentage of 
cells in each cell cycle phase was calculated by using Flowjo 7.5 software, 10000 cells per 
sample were be evaluated in each case.  
3.3.8 Fluorescence labelling of F-actin and cell nuclei  
The RAW264.7 cells were cultured and harvested and the concentration of cells was 
determined by counting. Subsequently, RAW264.7 cells suspension was prepared with 1×105 ml 
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in DMEM with 2 nM cytochalasin B (Sigma: C6762), 0.1 % DMSO (Biozol: EMR385250) and 
genistein 25 and 12.5 µM. 500 µl of the respective suspension were seeded into 4 well plates and 
cultured for 48 hours under standard conditions. Then, the supernatant was removed and the cells 
were washed twice with 750 µl PBS. After washing, the cells were fixed by addition of 750 µl 
3.7 % paraformaldehyde (PFA) for 15 min at room temperature. They were then again washed 
twice with PBS to remove the PFA and the cells were incubated with 750 µl 0.1 % Triton X in 
PBS for 5 min to permeabilize. After permeabilization, cells were washed twice with PBS and 
finally, 500 µl Alexa Fluor® 488-phalloidin (2 U/ml in PBS containing 10% FBS, Invitrogen: 
12379) was added for 1 hour at 37 °C in 10 % CO2. Since phalloidin specifically binds the 
F-actin, the actin filaments of the cells were fluorescently labeled. Then the cells were washed 
twice with PBS to remove unbound dye and stored in 500 µl PBS. 1µg/ml of DAPI (Invitrogen: 
P36931) was added into the wells, It can bind to the nuclei of the cells. Specimens were 
examined using fluorescence microscope. 
3.3.9 Detection of nitric oxide by Griess reagent 
Nitric oxide (NO) is an important physiological messenger and effector molecule in many 
biological systems, including immunological, neuronal and cardiovascular tissues( this depends 
more to the introduction) The indirect evidence of the release of nitric oxide (NO) by RAW264.7 
cells was carried out by Griess reaction [139]. NO, the unstable radical in aqueous solution, reacts 
with oxygen to form nitrite (NO2-) and a smaller amount of nitrate (NO3-) [140]. The detection is 
based on the chemical reaction (Griess-reaction) shown in Fig. 3.3, which uses sulfanilamide and 
N-1-napthylethylenediamine dihydrochloride (NED) under acidic (phosphoric acid) conditions. 
The product of this reaction can be detected at 540 nm using a photometer. 
 
Fig. 3.3 Chemical reactions involved in the measurement of NO2-using the Griess Reagent (Roche). 
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3.3.9.1 Sample preparation  
RAW264.7 cells were grown up to a confluence of approximately 80 % in standard 
conditions of cultivation and counted. 100 µl of 1 × 106 / ml cells suspension in DMEM were 
seeded into the wells of a 96-well plate, so that there were 1×105 cells per well. The cells were 
pretreated with different concentrations of genistein (0-100 µM) or other inhibitors (Tab. 3.3) for 
1 hour and then stimulated with LPS (100 ng / ml) for another 20 hours. Finally, 50 µl 
supernatant per well were transferred by a pipette to a reduced volume 96 well microtiter plate 
and then used for all other experiments. Cell viability was detected by WST-1 in parellel 
following the protocol described in 3.3.6.   
Tab. 3.3 Specific inhibitors used in the experiment 
 
Inhibitor Target Company  Solvent  Stock 
concentration 
Working 
concentration 
AG490 Jak2 (PTK) Biaffin( PKI-AG490-010) DMSO 34 mM 0.16-340 µM 
PP2 Src (PTK) Biaffin(PKI-PP2-001) DMSO 3.3 mM 0.4-33.3 µM 
Syk inhibitor Syk (PTK) Calbiochem (574712) DMSO 14 mM 1.6-14 µM 
PD98059 MEK1/2  Biaffin (PKI-PD98059) DMSO 18 mM 6.7-180 µM 
SB203580 P38MAPK Biaffin (PKI-SB203-001) DMSO 4 mM 2.2-20 µM 
U1026 MEK1/2  Cell signalling (9903) DMSO 10 mM 10 µM 
LY294002×HCL PI3-Kinase Sigma (L9908) DMSO 2 mM 0.27-22.2 µM 
Wortmanin  PI3-Kinase Sigma (W1628) DMSO 233 µM 0.013-23.3 µM 
Akt1/2 inhibitor Akt1/2 Sigma (A6730) DMSO 9 mM 0.4-33.4 µM 
Bpv(phen) Phosphatase  AlEXIS 
Biochemicals(ALX-270-204) 
Water 14 mM 1.6-14 µM 
3.3.9.2 Detection of nitrite in cell culture 
A standard method for detection of sodium nitrite (NaNO2) was used. Griess reagent was 
prepared by 1:1 mixing sulfanilamide (1 % in 5 % H3PO4) and N-(1 naphthyl) ethylendiamid 
(0.1 % dissolved in 5 % H3PO4). Samples prepared in 3.3.9.1 were mixed with 50 µl of the Griess 
reagent for 10min at room temperature. The calibration was made by dilution of NaNO2 (100 mM 
NaNO2 in H2O) to a concentration range from 0 to 100 µM by DMEM, 50 µl of this solution 
were mixed with 50 µl of the reagent, the samples were measured at 540 nm. For data analysis, a 
linear regression equation was calculated according to the values of the standard series. With this 
linear regression equation the nitrite concentration in the cell culture suspension was determined.  
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3.3.10 Cytokine determination 
3.3.10.1 Principle of the ELISA method 
The cytokine production by LPS stimulated macrophages was detected by Enzyme linked 
immunosorbent assay (ELISA) [141]. The principle of the method is shown below: 
 
Fig. 3.4 Principle of a sandwich ELISA (1) The ELISA plate is coated with a capture antibody (red); (2) 
Sample is added, and the respective antigen present binds to capture antibody (green); (3) Biotin-conjugated 
secondary detection antibody (blue/orange) is added, and binds to the antigen captured by the first antibody; (4) 
Streptavidin-HRP is added and binds to the biotin conjugated detection antibody (dark blue); (5) Coloured 
product (light blue) is formed in proportion to the amount of antigen present in the sample; The reaction is 
terminated by addition of acid and absorbance is measured at 450 nm. 
3.3.10.2 Sample preparation 
RAW264.7 cells were grown up to a confluence of approximately 80% in standard 
conditions of cultivation and counted. For TNF-α, 100 µl of 1 × 105 / ml cells suspended in 
DMEM were seeded into the wells of a 96-well plate. For IL-6 and IL-10, 100 µl of 5 × 105 / ml 
cells suspended in DMEM were seeded into the plate. The cells were pretreated with different 
concentrations of genistein or other inhibitors (Tab. 3.3) for 1 hour and then stimulated with 10 µl 
(1 µg / ml) LPS. The incubation time differed according to the interesting cytokines. For TNF-α  
determination the concentrations were detected after a incubation time of 1 and a half hour, IL-6 
were determined after 5 hours and IL-10 concentrations were determined after 6 hours. Finally, 
the supernatant was collected and stored at -20 °C. Cell viability was detected by WST-1 in 
parellel following the protocol described in 3.3.6. 
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3.3.10.3 ELISA-protocol 
Tab. 3.4  Reagents from ELISA READY SET GO! Kit-systems 
 
Coating buffer PBS-powder dissolved  in 1L MillQ H2O; 00-0044-59 
Coating antibody 250 times concentrated, diluted in coating buffer 
IL-10-Coating: anti-Mouse-IL-10; 88-7104-CP 
IL-6-Coating: anti-Mouse-IL-6; 88-7064-CP 
TNFα-Coating: anti-Mouse-TNFα; 88-7324-CP 
Block buffer 5 times concentrated in MillQ. H2O; 00-4202-AD2 
Detections antibody 250 times concentrated, diluted in block buffer, biotin-coupled 
IL-10-Detection: anti-Mouse-IL-10; 88-7104-DT 
IL-6-Detection: anti-Mouse-IL-6; 88-7064-DT 
TNFα-Detection: anti-Mouse-TNFα; 88-7324-DT 
Avidin-HRP 250 times concentrated, diluted in block buffer; 00-4100-EN2 
Substrate TMB solution, ready to use; 00-4201-SB 
Standard Recombinant mouse cytokine 1µg/ ml, dilution series in DMEM 
IL-10; 88-7104-ST 
IL-6; 88-7064-ST  
TNFα; 88-7324-ST 
 
The reagents used in the assay are listed in Tab. 3.4, the protocol is described as below:  
A reduced volume 96 well plate was filled with capture antibody in coating buffer (50 µl / 
well) and incubated over night at 4 °C. On the next day, the antibody solution was removed and 
the plate was washed with 150 µl wash buffer (PBS with 0.05 % Tween 20) at least 5 times. To 
increase the effectiveness of the washes, the plate was blotted on absorbent paper to remove any 
residual buffer. Then the wells were blocked with 1X assay diluents, incubated at room 
temperature for 1 hour, washed and 50 µl / well of samples were added. Standard serial dilutions 
were added to the appropriate wells for 2 hours, after washing, 50 µl / well of detection antibody 
diluted in 1X assay diluents were added for 1 hour. The plate was washed and then 50 µl / well of 
AvidinHRP* for 30 minutes were added. This was repeated for a total of 7 washes; then 100 µl / 
well of substrate solution to each well were added for 15 minutes. Finally, 50 µl of 2 M sulfuric 
acid (H2SO4) were added to each well to stop the enzymatic reaction. The plate was measured 
plate at 450 nm.  
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For data analysis, a linear regression equation was calculated according to the values of the 
standard series. The cytokine concentration in the cell culture suspension was calculated by the 
linear regression equation. Data were represented as means ±the standard deviation. 
3.3.11 Detection of NF-κB and AP-1 activation of RAW-BlueTM Cells 
The RAW-BlueTM cells were harvested and counted when the cells were grown up to a 
confluence of approximately 80 % in standard conditions of cultivation. 180 µl of 5×105/ ml of 
RAW-BlueTM cells were seeded in 96 well plates and treated with genistein (0-100 µM) 1hour 
before stimulation with 10 µl of LPS (1 µg / ml), incubated in normal culture condition for 20 h. 
40 µl of induced RAW-BlueTM cells supernatant were taken into a flat bottom 96 well plate, 160 
µL of resuspended QUANT-BlueTM (#rep-qbl) was added, SEAP levels were determined at OD 
620nm. 
3.3.12 RT2 Profiler TM PCR Array (PAMM-018G) for Toll-like receptor 
pathway 
RAW264.7 macrophages were grown up to a confluence of approximately 80 % in standard 
conditions of cultivation and counted. The cells were seeded in 25 cm2 flask with the 2×105 / ml 
and cultivated overnight. On the next day, the cells were incubated with or without genistein 50 
µM for 1 hour before stimulation with LPS (final concentration 100 ng / ml) for 6 h. Total RNA 
was prepared from cells using RNeasy Mini Kit (Qiagen) according to the manufacturer’s 
instructions. RNA was reconstituted in RNase free water; concentration and purity were 
determined using UV spectrophotometry. RNA integrity was verified by gel electrophoresis.  
A total of 0.5 µg RNA was used with RT2 First Strand kit (C-03) (Superarray, Fredrick, MD) 
with the addition of 2 µl of 2GE (5x gDNA elimination buffer). The RNA was incubated at 42°C 
for 5 minutes and placed on ice of 1 minute. RT cocktail of 4 µl of BC3 (5x RT buffer 3), 1 µl of 
P2 (primer & external control mix), 2 µl RE3 (RT enzyme mix) and 3 µl of RNase free water was 
added to each sample. The mixture was carefully pipetted and incubated at 42°C for 15 minutes 
and then heated at 95 °C for 5 minutes and placed on ice. 91 ml of double distilled water was 
added to each 20 µl of cDNA synthesis reaction. PCR was performed using 10 µl of the following 
mixture: 2000 µl of 2x SuperArray RT2 qPCR Master Mix, 102 µl diluted first strand cDNA 
synthesis reaction and 1898 µl of double distilled water in the wells of a 384-well microtiter plate. 
The amplification process included 1 cycle for 10 mins at 95°C, 40 cycles for 15 secs at 95°C, 
followed by 40 cycles for 1 min at 60°C. 
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Thermal cycling and fluorescence detection were performed using LightCycler 480 (Roche). 
The signals of the target cDNAs were normalized by comparison with the housekeeping genes 
(GAPDH, Actin, GUSB, HPRT1, HSP90, reverse transcription control, and positive PCR control) 
supplied within the 384-well microtiter plate. Final calculations were made using a web-based 
PCR Array Data Analysis tool (Superarray, Fredrick, MD). 
3.3.13 Western Blot 
RAW264.7 macrophage cells were grown up to a confluence of approximately 80 % in 
standard conditions of cultivation and counted.  The cells were pretreated with or without  
DMSO (as control), 100 µM genistein, 100 µM PD98059, 12 µM SB203580 or 10 µM U1026 for 
1 hour and then stimulated with LPS (100 ng / ml) in the presence of the inbitiors for 15 and 30 
min. Cells were washed with ice-cold PBS and scrapped. The whole cell lysates were prepared in 
ice-cold lysis buffer (50 mM Tris/HCl pH 7.5; 150 mM NaCl; 2 mM EDTA; 1 % Triton; 0.5 % 
Nonidet p-40 (Sigma); 100 × phosphatase and protease inhibitor cocktail set I (Roche, 
Calbiochem)). Lysates were clarified by centrifugation. Proteins were quantified by BCA assay 
and 30 µg protein/lane resolved by electrophoresis on 10-12 % SDS-PAGE. Resolved proteins 
were transferred onto PVDF membrane (Biorad, USA) by semi-dry transfer in blot buffer (Tris 
50 mM, Glycine 40 mM, 0.01 % SDS, and 4 % methanol) at 250 mA for 1 hour using the 
Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (Biorad, USA). Membranes were probed 
with primary antibody followed by HRP conjugated secondary antibody and detection by ECL 
chemi-illuminescence (RPN2132, Amersham, GE healthcare, USA). All primary antibodies were 
purchased from cell signal. Phospho-ERK1/2 pathway sample kit (9911), phospho-p38 MAPK 
(Thr180/Tyr182) (3D7) (9215) and P38 MAP kinase alpha (L53F8) mouse mAb (9228) were 
used at concentrations of 1:1000. Secondary antibodies were used at dilutions of 1:6666.  
3.3.14 Receptor staining of macrophages RAW264.7 
RAW264.7 macrophage cells were grown up to a confluence of approximately 80% in 
standard conditions of cultivation and counted. 1 ml of 106 cells / ml were washed with PBS 
containing 2 % FBS. The surface dectin-1 or TLR2 receptor expressions were detected 
respectively using TLR2 mAb (SC-52736, Santa Cruz Biotechnology, USA) or recombinant 
mouse Dectin-1/CLECA7 mAb (1756-DC-050, R&D Systems, USA). The cells were incubated 
for 1 hour with 200 µl of the antibody solution which was prepared by a 1 / 50 dilution of the 
delivered antibody. For detection of the primary antibody, cells were washed 3 times in PBS 
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containing 2 % FBS and incubated for 45 min with the Alexa Fluor 488-labeled anti-mouse 
antibody from goat as secondary antibody diluted 1 / 250. As negative control yeast cells were 
incubated only with the secondary antibody. All reactions were performed at room temperature. 
After washing, cells were fixed in 0.4 % formalin and analyzed by flow cytometry.  
Flow cytometry was performed with an FACS Canto equipped with an argon ion laser with 
an excitation power of 20 mW at 488 nm. Forward and side light scatter were analyzed on linear 
scales, while fluorescence intensity was determined on logarithmic scales. Analysis gates were set 
around debris and intact cells on a forward and side light scatter dot plot. The fluorescence 
histograms of 10,000 cells were generated using gated data. Data analysis was performed using 
Flowjo 7.5. 
3.4 Work with yeast 
3.4.1 Yeast strains 
All the C. albicans strains used in the experiment are listed in Tab.3.5. These were provided 
by R. Calderone (Georgetown University, USA) and Jesus Pla (Universidad Complutense de 
Madrid, Spain). In addition, the S. cerevisiae strain BY4741 was established in Euroscarf (Johann 
Wolfgang Goethe-University, Frankfurt am Main).  
Tab. 3.5 C. albicans strains used in this study 
3.4.2 Preparation of YPD and YP galactose medium 
YPD medium (yeast extract peptone dextrose) is a complex culture medium from yeast 
Strains Synonym Genotype Reference 
CAF2-1  ∆ura3::imm434/URA3 [142]  
∆chk1 CHK21 ∆ura3::imm434/∆ura3::imm434 
∆cahk1::hisG/∆cahk1::hisG-URA3-hisG 
[115]  
∆cek1 CK43B-16 ura3/ura3∆cek1::hisG/∆cek1::hisG-URA3-h
isG 
[143] 
∆mkc1 CM1613 ∆mkc1::hisG/∆mkc1::hisG-URA3-hisG [143] 
∆hst7 CDH12 ura3/ura3 ∆ hst7::hisG/∆hst7::hisG [144] 
∆pbs2 BRD3  ∆pbs2::cat/∆pbs2::cat-URA3-cat [117] 
∆hog1 CNC13 hog1::hisG/hog1::hisG-URA3-hisG 
∆his1::hisG/∆his1::hisG 
[145] 
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extract, peptone and glucose which was used for the cultivation of yeasts. The YPD medium was 
purchased from Sigma (Y1375) and according to the manufacturer's specifications 50 g of 
powder were dissolved in 1L MilliQ water. The sterilization of the medium was done as described 
in 2.3.1. 
YP galactose medium is a complex culture medium from yeast extract 10 g, peptone 20 g 
and galactose 20 g dissolved in 1L MilliQ water. The sterilization of the medium was done as 
described in 3.2.1 
3.4.3 Storage and cultivation  
1 ml yeast suspension from the stationary growth phase was stored in cryogenic tubes with 
YPD medium at -80 °C. For using, a tube was thawed at room temperature and cultivated 
overnight in an Erlenmeyer flask (100 ml) volume of 20 ml YPD medium at 30 °C with shaking 
(160 rpm). The next day, the yeast cells were used for an experiment or frozen for new storage.  
3.4.4 Labelling yeast with fluorescence dye 
The fluorescent labelling of yeast cells was carried out by the coupling of the fluorescein 
derivative fluorescein isothiocyanate (FITC) to amino groups of cell wall components of yeast. 
Yeasts were cultured in YPD medium as described in 3.4.3 and the cell number was determined 
(3.2.3). Subsequently, 1 × 108 yeast cells were transferred into a 1.5 ml reaction tube filled with 
PBS to 1 ml, harvested by centrifugation (16 000 × g, 5 min, 24 ° C). The supernatant was 
discarded and the pellet was resuspended in 1 ml PBS. This washing step was repeated twice 
before the yeasts were added in 1 ml of a dye solution of the dye (Tab. 3.6) and incubated 
overnight at 4 °C. The next day, the yeasts were washed three times with 1 ml of PBS, either used 
immediately or stored until use at -20 ° C. 
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Tab. 3.6 Property of the fluorescence dye 
 
 FITC 
Company Sigma 
Article number F7250 
Coupling group Isothiocyanate 
Excitationmax. 495 nm 
Emissionsmax 519 nm 
Storage 100 mg/ml in DMSO, 
-20 °C 
Final concentration 1.25 mM (500 µg/ml) 
Stain buffer 0.1 mM NaHCO3 + 0.5% 
DMSO, pH 9.0 
 
3.4.5 Genistein- treated C. albicans  
From the overnight cultures of yeast, the concentration of yeast suspension was determined. 
The yeasts were diluted into OD=0.2 in 20 ml YPD. After 2 hours preculture, the yeasts were 
diluted into OD=0.1 and different concentration of genistein were added for another 24 hours. 
The yeasts were then prepared for further experiments. 
3.4.6 Growth curve of yeast  
The investigation of the growth of yeast was based on the measurement of optical density 
(OD) of yeast suspensions using a multi-well photometer. The yeasts from an overnight culture 
were transferred (180 µl / well) into a column in a 96-well culture plate and measured at 620 nm. 
This preculture was diluted to an optical density (620 nm) of 0.2, for 2 h growth and started with 
OD=0.1 for working culture with or without genistein 100 µM treatment in YP galactose medium 
and determined the OD hourly by the microtiter plate reader µQuant. 
3.4.7 Measurement of oxygen consumption  
The test organisms S. cerevisiae BY4741 and C. albicans CAF2-1 were grown in YPD 
medium overnight at 30 °C on a shaker. The culture was diluted into OD=0.2 in 20 ml YP 
galactose. After 2-3 hours preculture, this culture was then diluted to an optical density (620 nm) 
of 0.15 (for S. cerevisiae) and 0.05 (for C. albicans) determined by the microtiter plate reader 
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µQuant.  
Oxygen consumption was measured by a fluorometric assay as previously described [146]. 
Round-bottomed OxoPlates® (PreSens, Regensburg, Germany) were used instead of the clear 
polystyrene microtiter plates. In a 96 well round-bottomed OxoPlates® (PreSens, Regensburg, 
Germany) (Greiner, Recklinghausen, Germany), compounds were serially diluted by a factor of 3. 
In the first column 30 µl of the working solution was added to 60 µl YP galactose medium; the 
other columns contained 60 µl medium to which 30 µl was added from the preceding column. By 
this procedure not only the compounds were serially diluted but also the amount of solvent, 
which was still 33% in the first column at this stage. Finally, for inoculation 120 µl of the diluted 
cell suspension was added. For C. albicans, all experiments were started with OD=0.05; for 
S .cerevisiae, OD started with 0.15. The plates were then incubated at 30 °C and 650 rpm using 
the Heidolph instruments Titramax 1000 shaker. 
The determination was done as described by the manufacturer i.e. fluorescence of the 
indicator and the reference dye was determined with a fluorescence microtiter plate reader 
(Cytofluor, Reader Series 4000, PerSeptive Biosystems) from the bottom using the excitation 
wavelength λex 530 nm and the emission wavelength λem 620 nm for the indicator and λex 530 nm 
/ λem 590 nm for the reference dye. Calibration was done with water saturated with air (100%) 
and with an aqueous Na2SO3 solution 1 g / 100 ml (0%) according to the supplier’s protocol. 
3.4.8 Measurement of ROS accumulation 
Endogenous amounts of ROS in yeasts were measured by a fluorometric assay using 
H2DCFDA, SE (Invitrogen, catalog number D-2935) as a ROS indicator as previously described 
[147]. The succinimidyl ester of 2’, 7’-dichlorodihydrofluorescein diacetate (H2DCFDA), is a 
chemically reduced and acetylated form of the highly fluorescent dye 2’,7’-dichlorofluorescein 
(DCF) (Fig. 3.5). 
Logarithmically growing C. albicans cells were suspended in sterile water to OD=0.5. Then 
H2DCFDA, SE was added from a stock solution of 2 mg/ml in DMSO to a final concentration of 
40µg/ml. After 30 min of incubation at 30 °C, the cells were collected by centrifugation and 
resuspended in sterile water. Then 120 µl of this mixture were added to a dilution series of 
genistein, rotenone and antimycin in a 96 well microtiter plate. The development of fluorescence 
was monitored after 2 hours at 30 °C at λex=485 nm and λem=535 nm through the bottom of the 
plates by a fluorescence multi-well plate reader.  
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Fig. 3.5 Principle of the detection: Nonfluorescent 5-(and-6)-carboxy-2‘,7‘-dichlorodihydrofluorescein 
diacetate (carboxy-H2DCFDA) permeates live cells and is deacetylated by nonspecific intracellular esterases. In 
the presence of ROS, which are produced throughout the cell, particularly during oxidative stress, the reduced 
fluorescein compound is oxidized and emits bright green fluorescence. 
3.4.9 Spectrophotometric assay of complex I activity with 
C. albicans 
From overnight cultures of C. albicans, precultures were prepared by diluting the overnight 
culture to an optical density (OD at 620nm) of 0.2 determined with the µQuant microtiter plate 
reader by taking 180 µl cell suspensions from overnight culture. This culture was allowed to grow 
for 2-3 hours until the exponential growth phase was reached. Then working cultures were 
prepared by diluting the pre-culture to OD620nm = 0.1, and adding of 12.3 µl of either DMSO or 
genistein and rotenone from the 200 mM stock solution, so that the final concentration of 
genistein was 123 µM, the final concentration of rotenone was 63.3 µM. The samples were taken 
after 3 hours by centrifugation. OD was measured in parallel. The supernant was discarded and 
the pellet was washed carefully with PBS at pH=7 for 2 times. The pellet was then suspended in 1 
ml PBS. 
To assay the redox activity of the complex I within the microorganisms, in the normal 96 
well plate 20 µl from the yeast suspension were added in the first 3 wells of the plate and then 
160 µl of DCIP (dichlorophenolindophenol) (D1878, Sigma) with 40 µM in PBS at pH 7 was 
added. Measurement of the change in the DCIP color at different times was carried out at 600 nm 
with the microtiter plate reader µQuant. 
3.4.10 Ethanol determination 
From overnight cultures of C. albicans and S. cerevisiae precultures were prepared by 
diluting the overnight culture to an optical density (OD at 620nm) of 0.2 determined with the 
µQuant microtiter plate reader, using 180 µl cell suspensions in 20 mL YPD. This culture was 
allowed to grow for 2-3 hours until the exponential growth phase was reached. Then working 
cultures were prepared by diluting the pre-culture to OD620 = 0.1 and 10 µl of either DMSO or 
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genistein from the 200 mM stock solution were added so that the final concentration of genistein 
was 100 µM. For ethanol determination 200 µL were taken as sample from the culture every hour 
and immediately centrifuged at 14,000 rpm and 4 °C for 10 minutes. The supernatants were 
stored in liquid nitrogen until ethanol was determined.  
Ethanol was determined as described previously [148]: All solutions of the enzyme mix 
were prepared in 100 mM NaPP buffer, or which 4.46 g were solved in 100 ml water. The pH was 
adjusted with phosphoric acid. The enzyme mix comprised alcohol dehydrogenase (ADH; 288 U 
/ mg; Fluka; stock solution: 3 U / µl NaPP, pH 7.5) and NAD+ (Biomol; stock solution: 11 Mm in 
NaPP, pH 8.5). For the preparation of the enzyme mix, 33 µl ADH were added to 5 ml NAD+ 
solution. Ethanol standards (50 mM) were prepared in YPD. In each well, 5 µl of the sample or 
the standard solution was placed, and the reaction was started by the addition of 45 µl of the 
enzyme mix. After incubation at room temperature for 30 min, the absorbance at 340 nm was 
determined with the microtiter plate reader (µQuant, Biotek). Four aliquots of each sample were 
analyzed.  
3.4.11 Flow cytometric analysis of cell wall glucans and mannans  
3.4.11.1 β-(1,3)-glucans analysis  
The accessibility of β-1, 3-glucans on the yeast cell wall was investigated by flow cytometry. 
The methods were performed according to Jouault et al [149]. β-1, 3-glucans were stained by a 
monoclonal antibody: 1 ml of 106 cells / ml were washed with PBS containing 2 % FBS and then 
incubated for 1 hour with 200 µl of the antibody solution which was prepared by an 1 / 150 
dilution of the delivered antibody. For detection of the primary antibody, cells were washed 3 
times in PBS containing 2 % FBS and incubated for 45 min with the Alexa Fluor 488-labeled 
anti-mouse antibody from goat as secondary antibody diluted 1 / 250. As negative control yeast 
cells were incubated only with the secondary antibody. All reactions were performed at room 
temperature. After washing, cells were fixed in 0.4 % formalin and analyzed by flow cytometry.  
Flow cytometry was performed with an FACS Canto equipped with an argon ion laser with 
an excitation power of 20 mW at 488 nm. Forward and side light scatter were analyzed on linear 
scales, while fluorescence intensity was determined on logarithmic scales. Analysis gates were set 
around debris and intact cells on a forward and side light scatter dot plot. The fluorescence 
histograms of 10,000 cells were generated using gated data. Data analysis was performed using 
Flowjo 7.5. 
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3.4.11.2 Mannan analysis  
The accessibility of mannan on the yeast cell wall was investigated by flow cytometry. 
Staining of the yeasts with FITC-labeled concanavalin A, which binds to carbohydrates, were 
performed according to Tkacz et al [150]. Yeast from an overnight culture was adjusted to a final 
optical density of 0.1 at 620 nm in 0.5 ml. The cells were washed twice with 0.9 % NaCl and 
collected by centrifugation and resuspended in 0.5 ml of the FITC-concanavalin A (stock solution 
with 1 mg/ml) diluted 1: 50 with 0.9 % NaCl. After 30min at room temperature, the cells were 
again collected by centrifugation and washed twice with 1 ml 0.9 % NaCl. All reactions were 
performed at room temperature. After washing, cells were fixed in 0.4 % formalin and analyzed 
by flow cytometry. 
Flow cytometry was performed with an FACS Canto equipped with an argon ion laser with 
an excitation power of 20 mW at 488 nm. Forward and side light scatter were analyzed on linear 
scales, while fluorescence intensity was determined on logarithmic scales. Analysis gates were set 
around debris and intact cells on a forward and side light scatter dot plot. The fluorescence 
histograms of 10,000 cells were generated using gated data. Data analysis was performed using 
Flowjo 7.5 software. 
3.4.12 Cell surface hydrophobicity (CSH) test  
CSH was measured by the biphasic separation method (Microbial Adhesion To 
Hydrocarbons) as described previously [151]. For each strain tested, 1.5 ml of yeast suspension 
(OD0=1) was placed into a clean glass tube and overlaid with 1 ml hexadecane (Sigma-Aldrich : 
52210). The samples were vortexed for 2 min and settled down for 10 min, the phases were 
allowed to separate. The OD 620nm was measured for the aqueous phase. Genistein treated 
yeasts were prepared as shown in (0). 
The Hydrophobicicty was determined with the help of the following formula: 
Hydrophobicity index= (OD0-OD620nm after hexadecane overlay)/ OD0×100 . 
3.5 Infection 
3.5.1 Phagocytosis assay 
Phagocytosis of C. albicans by macrophages was conducted using a fluorimetric 
phagocytosis test. It was quantified as described [152]. 100 µl of 2 × 106 macrophages/ml were 
seeded in each well of 96 well microtiter plates followed by incubation for 2 hours to let the cells 
3  Material and methods                                                                                49                      
 
adhere to the plates. Macrophages were pre-incubated for 2 hour with the test compounds, before 
FITC-stained C. albicans was added. The ratio of macrophages: yeast was 1 : 2. For 24 hours 
genistein treatment 1 × 106 macrophages / ml were used. For 48hours genistein treatment of 
macrophages the cell concentration was 0.5 × 106 macrophages / ml. In this way, there are 
enough cells for the phagocytosis assay. Phagocytosis was allowed to proceed at 37 °C in 10 % 
CO2 for different periods of time. The medium was removed and 100 µl trypan blue (Fluka, 250 
µl / ml in PBS) were added to quench the fluorescence of yeasts which were not internalized. 
After an incubation of 1 min at room temperature, the trypan blue solution was removed. The 
number of internalized yeasts was estimated from fluorescence measurements (λEx=480 nm and 
λEm= 520 nm) through the bottom of the plates by a fluorescence multi-well plate reader.   
3.5.2 Cytokine detection by ELISA 
3.5.2.1 Samples preparation 
The cells were harvested and counted under normal culture condition. 100 µl of 3 × 105 
macrophages / ml were seeded in each well of 96 well microtiter plates and allowed to adhere for 
2 hours. 1× 108 C. albicans / ml were harvested from culture with or without genistein by 
centrifugation (13,000 rpm, 5 min, 24 °C), and washed twice with 1 ml PBS. They were 
suspended in DMEM cell culture medium. The supernatant was removed from the cell culture 
and 100 µl of the yeast suspension were added. When macrophages were treated with genistein, 
the compound was added 1 hour before the yeast was added. The ratio of macrophages: yeast was 
1:10 in all experiments. TNF-α concentrations were determined after yeast–macrophage 
incubation time of 1 hour, IL-10 concentrations were determined after 5 hours. The supernatant 
was collected by centrifugation (3000 rpm 5 min 4 °C). These samples were analyzed either 
immediately by ELISA or stored in -80°C. The detection was done as described in (0). 
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4 RESULTS  
4.1 Effect of genistein on the function of RAW264.7 
macrophages 
4.1.1 Cell viability  
Genistein is known to inhibit cell proliferation of human breast cancer cells (MCF-7), 
human ovarian cancer cells (HeLa), and human prostate cancer cells (PC3) [153-155]. We tested 
the influence of genistein concentrations and incubation times on the viability of the macrophages 
by the WST-1 assay. 
The results showed that genistein has an inhibitory effect on the cell viability in a time- and 
dose-dependent manner (Fig. 4.1). When the macrophages were treated with genistein for the 
short time of only 2 h, none of the genistein concentrations led to decreased signals. However, 
when the incubation time was extended to 24 and 48 hours, genistein concentrations of 100 - 50 
µM reduced the cell viability to 70 % - 80 % and 50 % - 60 % after 24 and 48 hours treatment (P 
<0.01), respectively. With lower genistein concentrations, no influence on the cell viability was 
observed. 
 
Fig. 4.1 Effects of genistein on the viability of macrophages determined by the WST-1 assay. Data are 
given with respect to the solvent control (100 %) and are the average of three independent experiments. 
**: p<0.01 compared with solvent control.  
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4.1.2 Cell cycle 
Genistein was described to arrest the cell cycle of human gastric cancer cells (HGC-27) and 
human breast adeno-carcinoma cells (MCF-7), as well as neuronal cells at the G2/M phase 
[156-159]. To elucidate whether the reduction of signals in the WST-1 test was due to a decreased 
proliferation rate, which could be caused by a cell cycle arrest, the influence of genistein on the 
cell cycle of macrophages was investigated by flow cytometry.  
 
 
Fig. 4.2 The cell cycle distribution of macrophages after treatment with genistein for 24 hours. The cell 
cycle distribution was determined by flow cytometry after PI staining. All experiments were performed in 
duplicate and gave similar results.  
 
As shown in Fig. 4.2, genistein treatment induced a significant accumulation of cells in the 
G2/M phase of the cell cycle in a concentration- and time-dependent manner, with a parallel 
depletion of the percentage of cells in G0/G1. When the macrophages were treated with genistein 
for 24 hours, the percentage of cells in S phase was between 20 - 30%, independent on the 
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genistein concentration. However, the number of cells in the G2/M phase increased significantly 
from 8.5% to 27.3% and 18.6%, for 100 and 50 µM genistein, respectively. The numbers in the 
G0/G1 phase decreased from 61.6 % to 36.9 % and 49.1 % respectively.  
The effect was more striking when the incubation time was extended to 48 hours, which also 
influenced the amount of cells in the S phase (Fig. 4.3): the amount of cells in the S phase 
increased from 15.8 % to 29.7 % and 19.5 %, respectively. The percentage of cells in the G2 / M 
phase increased from 11.4 % to 51.9 % and 30 %, respectively, whereas the percentage in the G0 
/ G1 phase decreased only slightly for 50 µM genistein from 67.2 % to 51.8 % but significantly to 
9.2 %, when 100 µM genistein was used. Lower concentrations of genistein had no obvious effect 
on the cell cycle of the cells.  
 
 
Fig. 4.3 The cell cycle distribution of macrophages after treatment with genistein for 48 hours. The cell 
cycle distribution was determined by flow cytometry after PI staining. All experiments were performed in 
duplicate and gave similar results.  
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4.1.3 Morphology  
Microscopic observations revealed that genistein influenced the morphology of the 
RAW264.7 macrophages. Thus, pictures were taken with an inverted contrast microscope after 
treatment of the cells with genistein for 2, 24, and 48 hour. Aberrations in cellular morphology 
were observed in a time- and dose-dependent manner (Fig. 4.4). After 2 hours of treatment, the 
cells were round and well attached to the bottom of the plates. The different concentrations of 
genistein exerted no effects on the morphology. After 24h, the cells were confluent and round in 
the control culture; whereas, in the genistein-treated culture, the cells were well attached, but the 
cell size increased and showed irregular shapes such as diamond shapes or pseudopodia-like 
protrusions. After 48h, these morphological changes became even more obvious. 
 
Fig. 4.4  Morphological change of macrophages RAW264.7 after treatment with genistein. Different 
concentrations of genistein were incubated for 2 h (Top), 24h (Middle) and 48h (Bottom); (A) Control, (B) 
12.5µM, (C) 25µM. The pictures were taken under the inverted contrast microscope. They are representatives 
of three independent experiments which were repeated on different days. 
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4.1.4 F-actin cytoskeleton  
The cytoskeleton of cells consists of highly dynamic actin polymer structures that play a 
critical role to maintain cellular morphology. As genistein significantly altered the morphology of 
macrophage cells (Fig. 4.4), we examine the effects of genistein on the cytoskeleton network in 
RAW264.7 macrophages. 
Cytochalasin B is a well known cytoskeleton inhibitor, which blocks actin polymerization by 
preventing the binding of monomeric G-actin to the growing (+) end of actin filaments (F-actin) 
[160]. Cytochalasin B also inhibits cell division by destruction of the contractile ring [161]. As it 
is shown in Fig. 4.5, there is clear difference between cytochalasin B-treated (Fig. 4.5 B) and 
untreated (Fig. 4.5 A) cells. Cytochalasin B-treated cells were round and had three nuclei, and the 
filament structures were not visible; whereas the untreated cells were round and the actin 
filaments were clearly discernible at the edges of the cells. After genistein treatment of the 
macrophages, changes of the F-actin structure were obviously induced: (i) the cell size increased 
and the cells had two nuclei, a long pseudopodia-like protrusion was formed after treatment with 
100 µM genistein; (ii) lobopodia-like protrusions were formed after treatment with 50 µM 
genistein; (iii) whereas macrophage treated with 25 µM genistein showed a typical spindle 
morphology, the actin was clearly stained at the edges of the cells and had long pseudopodia-like 
protrusions. Macrophage treated with 12.5 µM genistein showed similar effect. 
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Fig. 4.5 Effect of cytochalasin B and genistein on the actin cytoskeleton of macrophage RAW 264.7.  
The cells were incubated with cytochalasin B 2 nM (B) and genistein (C – F) for 48 hours, the actin filaments 
were stained with Alex488-phalloidin (Green fluorescence) and the cell nuclei were stained with DAPI (Blue 
Fluorescence), the pictures are the overlay of both fluorescence channels. (A) DMSO; (B) Cytochalasin B 2nM; 
(C) Genistein 100µM; (D) Genistein 50µM ; (E) Genistein 25µM; (F) Genistein 12.5 µM. 
 
4.1.5 Nitric oxide production of macrophages stimulated by LPS 
One of the major functions of macrophages is the production of signalling compounds and 
of reactive oxygen and nitrogen (nitric oxide, NO) species to kill foreign material. Thus, the 
effects of genistein on NO synthesis in RAW264.7 macrophages were investigated. The 
macrophages were stimulated with LPS and genistein for 20h. The NO production was 
determined via the nitrite concentrations in the culture medium using the Griess reaction. As 
shown in Fig. 4.6, cells treated with LPS for 20 h produced high amounts of nitrite (32±4 µM), 
which were 10-fold higher than the basal production of the unstimulated cells (3±1 µM). A 
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marked reduction of nitrite production was observed after genistein treatment (12.5 - 100µM). 
Cell viability of the macrophages stimulated with LPS and genistein was analyzed with the 
WST-1 assay to exclude the possibility that the inhibitory effect of genistein was due to cytoxic 
effects (Fig. 4.6). The viability of all cultures was not affected by any of the treatments and 
generally was > 90%. This result indicated that the inhibition of nitrite production by genistein 
was not due to cell death. 
 
Fig. 4.6 Influence of genistein on the NO production and viability of LPS stimulated RAW264.7 
macrophages. Left Y-axis: nitrite concentrations in the cell culture supernatants of LPS treated macrophages in 
the presence or absence of different concentrations of genistein. Results are expressed as means ± SD; n=8. 
Right Y-axis: Cell viability of LPS treated macrophages in the presence and absence of genistein.The cell 
viability of the solvent control (0 µM genistein) was 100 %. Results are expressed as mean ± SD; n=8.  
**: p<0.01 compared with control. 
4.1.6 Nitric oxide production of macrophages stimulated by IFN-γ 
and IFN-γ+ LPS 
IFN-γ exhibits a wide spectrum of biological activities, for example antiviral 
immunomodulatory effect. Not only the endotoxin LPS but also cytokines, such as IFN-γ, 
stimulate macrophages to produce NO. A combination of IFN-γ plus LPS is usually used to 
achieve the maximal induction of NO in macrophages. Therefore, we determined the genistein 
effect on the macrophages stimulated with (i) IFN-γ and (ii) IFN-γ plus LPS for 20 h. As shown 
in Fig. 4.7, genistein led to a dose-dependent inhibition of nitrite accumulation by IFN-γ alone 
and in combination with LPS. Cells treated with IFN-γ / IFN-γ+ LPS for 20 h produced a high 
level of nitrite (30±2 µM, 52±2 µM), which was significantly higher than the basal production of 
4  Results                                                                                             57                      
 
the unstimulated cells (0 µM). A marked reduction of nitrite production was observed after 
genistein treatment (4 - 111 µM genistein for IFN-γ, 37 - 111 µM genistein for IFN-γ + LPS). 
 
Fig. 4.7 Influence of genistein on the NO production of IFN-γ and LPS+IFN-γ stimulated RAW264.7 
macrophages. Nitrite concentrations in the cell culture supernatants of IFN-γ and LPS+IFN-γ treated 
macrophages in the presence or absence of different concentrations of genistein. Results are expressed as 
mean± SD; n=8.  
**: p<0.01 compared with control. 
4.1.7 Cytokine production of macrophages stimulated by LPS  
The effects of genistein on the production of the cytokines TNF-α, IL-6, and IL-10 by 
RAW264.7 macrophages were investigated. As shown in Fig. 4.8, genistein showed a 
dose-dependent inhibition of the cytokine accumulation in the supernatants of the LPS activated 
macrophages. After 1.5 h of stimulation, LPS-treated cells produced a high level of TNF-α 
(1100±50 pg/ml), which were 5-fold higher than the basal production (200±20 pg/ml). This 
LPS-induced TNF-α production could be significantly reduced by incubation with the highest 
genistein concentration of 100 µM. After 5 hour of stimulation, the induction of IL-6 secretion by 
LPS could also be detected (390±26 pg/ml in comparison to 0 pg/ml of untreated cells). Even the 
lowest concentration of genistein (3.7 µM) resulted in a significant reduction of the IL-6 
production. After 6 hours, high levels of IL-10 (5190±260 pg/ml) were measured (unstimulated 
cells: 1130±503 pg/ml), which were reduced by elevated genistein concentrations of 33-100 µM. 
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Cell viability of the macrophages stimulated with LPS and genistein for 6 hours was analyzed to 
exclude the possibility that the inhibitory effect of genistein was due to cytoxicity. The viability 
of all cultures was not affected by any of the treatments and generally was > 80%. This result 
indicated that the inhibition of nitrite production by genistein was not due to cell death. 
 
 
Fig. 4.8 Dose-dependent inhibition of 
cytokine production by genistein in the cell culture 
supernatants of LPS-activated macrophages. 
TNF-α was detected after 1.5 hours, IL-6 after 5 
hours, and IL-10 after 6 hours. Right y-axis: red 
line shows the cell viability after LPS and genistein 
treatement for 6 hours. Results are expressed as 
mean ± SD; n=4.  
**: p<0.01 compared with control;  
*: p<0.05 compared with control. 
4.1.8 Specific kinase inhibitor involved in LPS and IFN-γ pathway 
4.1.8.1 NO production  
Genistein inhibits the NO production induced by LPS and IFN-γ as well as by the 
combination of LPS + IFN-γ. Genistein is, in addition, a well known tyrosine kinase inhibitor. 
Therefore, we examined which tyrosine kinases and downstream kinases are involved in this 
process. We found that tyrosine kinases Syk, Jak2, Src, PI3Kinase, and Akt kinase are involved in 
the LPS-induced NO production in a concentration-dependent manner; whereas, tyrosine kinases 
(Syk and Jak2, but not Src), PI3 kinase, and Akt kinase are involved in the IFN-γ-induced NO 
production in a concentration-dependent manner (Tab.4.1).   
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Tab. 4.1 Effects of specific kinase inhibitors in NO production by LPS, IFN-γ and LPS+ IFN-γ stimulated 
RAW264.7 macrophages. 
 
Target kinase Inhibitor LPS IFN-γ LPS+ IFN-γ 
Jak2 AG490 0.16-340 µM 4.2-340 µM 12.6-340 µM 
Src PP2 3.7-11.1 µM ---- 11.1µM 
Syk Syk inhibitor 4.7-14 µM 4.7-14 µM 4.7-14 µM 
MEK1/2 PD98059 ---- ---- ---- 
P38 SB203580 26.7µM ---- ---- 
PI3K LY294002 0.82-22.2 µM 7.4-22.2 µM 7.4-22.2 µM 
PI3K Wortmanin  2.6-7.8 µM 2.6-7.8 µM 2.6-7.8 µM 
AKT Akt1/2 inhibitor 0.13-33.3 µM 33.3 µM 11.1-33.3 µM 
PTP Bpv(phen) ---- ---- ---- 
4.1.8.2 Cytokine production  
As shown in Tab.4.2, specific kinase inhibitors showed a dose-dependent inhibition of the 
cytokine (TNF-α, IL-6, and IL-10) accumulation in the supernatants of LPS-activated 
macrophages. Tyrosine kinases (Syk, Jak2, and Src), MAP kinase, PI3 kinase, Akt kinase, and 
protein phosphotyrosine phosphatase (PTP) are involved in the production of cytokine IL-6, 
IL-10, and TNF-α. 
Tab. 4.2 Specific kinase inhibitors effect on the cytokine productions in the cell culture supernatants of 
LPS-activated macrophages. TNF-α was detected after 1.5 hours, IL-6 after 5 hours, and IL-10 after 6 hours. 
 
Target kinase Inhibitor  IL-6 IL-10 TNF-α 
Jak2 AG490 12-37 µM 12-37 µM 12-37 µM 
Src PP2 0.4-11.1 µM 0.4-11.1 µM 1.2-33 µM 
Syk Syk inhibitor 1.6-14 µM 1.6-14 µM 1.6-14 µM 
MEK1/2 PD98059 180 µM 6.7-180 µM 6.7-180 µM 
P38 SB203580 2.2-20 µM 2.2-20 µM 2.2-20 µM 
PI3K LY294002 0.27-22.2 µM 0.27-22.2 µM 0.27-22.2µM 
PI3K Wortmanin  0.013-7.8 µM 0.013-7.8 µM 1.3-7.8 µM 
AKT Akt1/2 inhibitor 0.4-33.3 µM 0.4-33.3 µM 0.4-33.3 µM 
PTP Bpv(phen) 1.6-14 µM 1.6-14 µM 4.7-14 µM 
 
Note: The concentration ranges, shown in the Tab.4.1 and Tab.4.2, led to a strong inhibition of NO and cytokine 
production to less than 70 % compared with solvent control, but had no influence of the cell viability.  
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4.1.9 Influence of genistein on the LPS-induced MAP kinase 
phosphorylation 
MAP kinase pathways are involved in the LPS-induced macrophage activation [162]. To 
further delineate and confirm the signalling process involving MAP kinases in the regulation of 
LPS-induced activation of macrophages by genistein, we evaluated the induction of their 
phosphorylation by performing western blot analysis.  
 
Fig. 4.9  Determination of the activation of the MAP Kinase signalling cascade in lysis of macrophages 
exposed to LPS and genistein for different time intervals. Macrophages were pretreated with different inhibitors 
for 1 hour and then stimulated with LPS in the presence of inhibitors for 15 min and 30 min. Western blot 
analysis of p-Raf, p-MEK1/2, p-ERK1/2, p-p90rsk, p-p38, and p38.  
 
As shown in Fig. 4.9, phosphorylation of Raf, MEK1/2, and ERK1/2 after LPS treatment 
was detectable after 15 minutes post-stimulation and sustained until 30 minutes. Phosphorylation 
of p38 after LPS treatment is not as obvious as p-ERK1/2. However, genistein together with LPS 
showed a strong phosphorylation of ERK1/2, the downstream protein p90rsk, as well as p38. 
Using specific kinase inhibitors as control, the results showed that the specific MEK1/2 kinase 
inhibitors U1026 and PD98059 significantly inhibited the phosphorylation of MEK1/2 and 
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ERK1/2, and slightly increased p38 phosphorylation; while the specific kinase inhibitor for p38 
(SB203580) inhibited the phosphorylation of p38 and increases MEK/ERK1/2 phosphorylation. 
4.1.10 NF-κB and AP-1 activation detected with RAW-BlueTM Cells 
RAW-Blue™ cells are derived from RAW264.7 macrophages. They are stably transfected to 
express a secreted embryonic alkaline phosphatase (SEAP) gene inducible by NF-κB and AP-1 
transcription factors, so that the gene product SEAP is detectable in the supernatant upon TLR, 
RLR, or NOD stimulation. LPS is a standard stimulus for the TLR-4 receptor pathway. Thus, 
RAW-Blue™ macrophages were treated with LPS and genistein for 20h and the activity of SEAP 
was detected. LPS showed a strong activation of NF-κB and AP-1 as shown in Fig. 4.10. 
Genistein caused a dose-dependent inhibtory effect on the activation of NF-κB and AP-1. A 
strong inhibition of NF-κB and AP-1 activation was observed for the highest genistein 
concentration of 100 µM (p<0.01); whereas, at lower concentrations effects were less pronounced 
(33 µM genistein inhibitory effect with p<0.05). The cell viability result shows that the inhibitory 
effect is not due to toxicity effects.                                                                                                                             
 
Fig. 4.10 Inhibitory effect of genistein on NF-κB and AP-1 activation of RAW-BlueTM cells by LPS. 
Right Y-axis: Cell viability of LPS treated RAW-BlueTM cells in the presence and absence of genistein.The cell 
viability of the solvent control (0 µM genistein) was 100 %. Results are expressed as means ± SD; n=4. 
**: p<0.01 compared with control; *: p<0.05 compared with control. 
 
62                             The cellular and molecular properties of genistein against C. albicans infection 
 
4.1.11 Gene expression related to Toll-like receptor pathways  
In order to confirm the genistein effect on the macrophages in the transcriptional level, we 
used a Toll-like receptor pathway PCR array to analyze the expression of related genes after 
treatments with (i) LPS and (ii) LPS together with genistein. A significant number of genes were 
differentially regulated compared to control cells (Fig. 4.11) (Appendix). Genistein alone could 
up-regulate the genes CD80, MEKK1, c-fos, Rela, and Ticam2. LPS could up-regulate 20 genes 
including (a) cytokines IFN-β, IL-10, IL-1α, IL-1β, IL-6, TNF-α, Csf2, and Csf3; (b) chemokines 
Ccl2 and Cxcl10; (c) cyclooxygenase 2 (COX-2); (d) transcription factor NF-κB1; and (e) IκB-α. 
Whereas genistein shows a strong inhibition of the expression of these genes. Moreover, genistein 
treatment in LPS-stimulated macrophages could up-regulate the transcription factor IκB-β and 
c-Rel.  
 
Log FC  
Fig. 4.11 Hierarchical clustering of 32 induced or repressed genes. Genes passing appropriate filter criteria 
were subjected to a hierarchical clustering. The homology tree plot is shown on the left side. 1: Genistein- 
treated (50µM) macrophages RAW 264.7; 2: LPS -treated (100 ng/ml) macrophages RAW 264.7; 3 means 
LPS+ Genistein treated macrophages RAW 264.7. 
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4.2 Effects of genistein on C. albicans 
4.2.1 Genistein effects on the oxygen consumption of C. albicans 
and S. cerevisiae 
In order to investigate the action of genistein on the mitochondrial function of C. albicans 
and S. cerevisiae, the rates of oxygen consumption in the presence of genistein (123-1.5 µM) were 
determined. For C. albicans, an inhibitory effect of genistein on oxygen consumption was 
observed (Fig. 4.12 A) after 10 min. Within the applied genistein concentration range from 1.5 to 
123 µM, an influence of genistein concentration was observed. All cultures containing genistein 
showed higher oxygen concentrations, i.e. the respiratory rate was lower, than in cultures without 
genistein. However, for S. cerevisiae, no significant effect of genistein on oxygen consumption 
could be detected, even at the highest concentration of 123µM (Fig. 4.12). 
  
Fig. 4.12 Effect of genistein on the oxygen consumption of C. albicans (A) and S. cerevisiae (B). Oxygen 
consumption was measured in the OxoPlates® at the indicated times. The results represent two independent 
experiments.  
 
4.2.2 Effect of genistein on the ROS accumulation in C. albicans 
and S. cerevisiae 
Interference with the electron transport chain could lead to incomplete reduction of electron 
carriers, such as ubiquinones, which can induce the formation of reactive oxygen species (ROS) 
due to the subsequently incomplete reduction of oxygen. The fluorescent probe H2DCFDA, is 
suitable for measurement of ROS formation in yeast cells [163], and was used to monitor ROS 
formation in C. albicans and S. cerevisiae. Genistein caused an increase in the fluorescence 
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intensity of C. albicans as shown in Fig. 4.13. After 2 h of incubation with genistein, the 
increased ROS generation was seen. At a concentration of 41µM, 13.8µM, and 4.6µM of 
genistein the increase was 1.26, 1.41, and 1.26 times compared with the control (p<0.01), 
respectively. These data indicated that genistein induced ROS accumulation in C. albicans. 
On the other hand, genistein had no influence on ROS production of S. cerevisiae as shown 
in Fig. 4.13. After 2 h of incubation with genistein, no increase of ROS generation was observed. 
These data indicated that genistein did not induce ROS accumulation in S. cerevisiae. 
 
 
Fig. 4.13 Effects of genistein on the generation of endogenous ROS in C. albicans (A) and S. cerevisiae 
(B). Data represents the percentage of solvent control.  
 
4.2.3 Effect of specific respiratory chain inhibitors on oxygen 
consumption and ROS production in C. albicans  
4.2.3.1 Effect of rotenone on the oxygen consumption of C. albicans and        
S. cerevisiae 
In the respiratory chain of S. cerevisiae, the classical complex I for NADH oxidation is 
missing [133]. Instead, it has two groups of rotenone-insensitive NADH dehydrogenases called 
NDI and NDE, which are NADH dehydrogenases placed at the inner (NDI) and at the external 
(NDE) side of the mitochondrial membrane. As the respiratory chain of C. albicans contains 
complex I, we speculated that this part of the respiratory chain may be the site of action of 
genistein. Thus, we used the specific complex I inhibitor rotenone to test its effects on oxygen 
consumption.  
The rates of oxygen consumption in the presence of rotenone (34.8-3.9 µM) were determined. 
For C. albicans, a slightly inhibitory effect of rotenone on oxygen consumption was observed 
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( Fig. 4.14 A). However, for S. cerevisiae, no effect of rotenone on oxygen consumption was 
observed ( Fig. 4.14 B). 
 
 
 
 Fig. 4.14  Effects of rotenone on the oxygen consumption of C. albicans and S. cerevisiae. Oxygen 
consumption was measured in the OxoPlates® at the indicated times (A) C. albicans (B) S. cerevisiae 
 
4.2.3.2 Effect of rotenone on the ROS accumulation in C. albicans and          
S. cerevisiae 
Rotenone also caused an increase in the fluorescence intensity of C. albicans as shown in 
Fig. 4.15. After 2 h of incubation with rotenone, an increased ROS generation was seen for 
concentrations exceeding 10 µM. These data indicated that the specific complex I inhibitor 
rotenone induced ROS accumulation in C. albicans as well. 
On the other hand, rotenone had no influence on ROS production of S. cerevisiae after 2 h of 
incubation with rotenone, suggesting that rotenone did not induce ROS accumulation in S. 
cerevisiae. 
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Fig. 4.15 Effects of rotenone on the generation of endogenous ROS in C. albicans and S. cerevisiae. Data 
represents the percentage of solvent control. 
4.2.3.3 Effect of antimycin A on the oxygen consumption of C. albicans and     
S. cerevisiae 
Antimycin A is a specific inhibitor of the complex III of the respiratory chain for both C. 
albicans and S. cerevisiae. The rates of oxygen consumption in the presence of antimycin A 
(16.4-0.6 µM) were determined. For C. albicans, a strong inhibitory effect of antimycin A on the 
oxygen consumption was already observed (Fig. 4.16 A) after 10 min. Moreover, for S. cerevisiae, 
antimycin A also showed a striking inhibition of oxygen consumption in the concentration range 
16.4-0.6 µM (Fig. 4.16 B). 
 
 
Fig. 4.16 Effects of antimycin A on on the oxygen consumption of C. albicans and S. cerevisiae. Oxygen 
consumption was measured in the OxoPlates® at the indicated times (A) C. albicans (B) S. cerevisiae). 
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4.2.3.4 Effect of antimycin A on the ROS accumulation in C. albicans and       
S. cerevisiae 
Both C. albicans and S. cerevisiae showed a significant increase in ROS production when 
treated with antimycin A, as shown in Fig. 4.17. For C. albicans, at a concentration of 16.4 µM, 
5.4 µM, 1.8 µM, and 0.6 µM of antimycin A, the increase was 2.05, 1.93, 1.84, and 1.85 times 
respectively compared with the control (p<0.01). On the other hand, antimycin A had a strong 
influence on ROS production of S. cerevisiae as it is shown in Fig. 4.17 B, which shows an 
increase of 1.68, 1.64, 1.62, and 1.60 times respectively compared with the control (p<0.01).   
 
 
Fig. 4.17 Effects of antimycin A on the generation of endogenous ROS in C. albicans and S. cerevisiae. 
Data represent the percentage compared to solvent control. 
 
4.2.4 Complex I activity  
Dichlorophenolindophenol (DCIP) is used as artificial electron acceptor for complex I 
reductase activity. The oxidized form of blue DCIP can be reduced and turned into a colorless 
reduced form in the presence of C. albicans cells. Rotenone is an inhibitor of complex I, and thus 
inhibits the catalysed oxidation of NADH by DCIP. Fig. 4.18 shows DCIP reduction by the 
suspension of C. albicans. There is no difference between genistein-treated C. albicans and the 
control. However, rotenone strongly blocked the DCIP reduction. Thus, genistein shows a 
behavior different from rotenone. 
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Fig. 4.18  The consuming of the DCIP color by suspensions cells of genistein (123 µM) and rotenone 
(63.3 µM) treated C. albicans after 20 min.  
4.2.5 Ethanol production 
As inhibition of the respiratory chain results in the redirection of metabolic pathways in 
favour of fermentative reactions, we detect ethanol in the culture supernatants (Fig. 4.19). The 
results showed that genistein (100 µM) led to a significant increase in ethanol productivities after 
treatment of C. albicans for 4 hours. 
 
Fig. 4.19 Effects of genistein on the ethanol production of C. albicans after genistein treatment for 4 hours. 
The results represent at least two independent experiments. 
  
4.2.6 Growth of C. albicans  
Rotenone is a specific complex I inhibitor, which does not prevent C. albicans proliferation 
[198]. According to the literature, we tested whether genistein could influence the growth of C. 
albicans. Growth was followed via the determination of the turbidity at OD 620nm. As shown in 
Fig. 4.20, genistein (123 µM) had no effect on the growth rate of C. albicans from 0 - 5 hour 
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growth compared with DMSO control. 
 
Fig. 4.20 Effect of genistein on growth of C. albicans in YPgal medium. The results represent at least two 
independent experiments. 
4.2.7 Cell wall β-glucans and mannans components of C. albicans  
β-1,3-glucans are reported to be essential for the recognition of C. albicans by the 
macrophage receptor dectin-1, the main receptor for phagocytosis of C. albicans. Therefore, we 
investigated whether genistein changed the cell wall structure and enhanced the accessibility of 
β-1,3-glucans on the surface of C. albicans. As shown in   Fig. 4.21, treatment of C. albicans 
with genistein (100 µM) did not lead to an increase of the accessibility of β-1,3-glucans compared 
with DMSO control.  
Mannan is another important cell wall constituent of C. albicans, which plays a role in the 
interaction between pathogen and host. So, we investigated whether genistein could influence the 
accessibility of mannans on the surface of C. albicans. As shown in Fig. 4.21, treatment of C. 
albicans with genistein (100 µM) did not lead to any influence of the accessibility of mannan 
compared with DMSO control.  
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  Fig. 4.21 FACS analysis of accessible β-1,3-glucans and mannan of genistein 100 µM treated C. albicans 
CAF2-1. The results presented are representative of three independent experiments. 
 
4.2.8 Cell surface hydrophobicity of C. albicans  
Cell surface hydrophobicity (CSH) was associated with an increased virulence of C. 
albicans due to stronger adherence to substrates [164, 165]. Therefore, we investigated the 
influence of genistein on the CSH of C. albicans. Hydrophobic and hydrophilic cells were 
separated using the biphasic separation method. As shown in Fig. 4.22, genistein (100 µM) 
treatment led to a 5 % increase of the cell surface hydrophobicity of C. albicans compared with 
the solvent control (p<0.01).  
 
Fig. 4.22 Effect of genistein on the cell surface hydrophobicity of C. albicans. Results presented are 
representative of three independent experiments. 
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4.3 Infection  
4.3.1 Receptor expression on macrophage surface related to  
C. albicans infections 
Macrophages express high levels of Toll-like receptors (TLRs) on their cell membranes, as 
well as lectin receptors. Among them, Toll-like receptor 2 and dectin-1 receptor are important for 
recognition of C. albicans infections. The expression of the receptors may differ with different 
macrophage cell lines. Therefore, it is necessary to confirm the presence of receptors in the 
macrophage cell line RAW264.7. As shown in Fig. 4.23, macrophages RAW264.7 expressed 
high levels of TLR-2 and dectin-1 compared with the control which was only stained with the 
secondary antibody.  
 
 
Fig. 4.23  Receptors expression of macrophage RAW264.7 by flow cytometry. The overlay of control: 
staining with only secondary antibody (grey area) and the first antibody staining (white area). 
4.3.2 Phagocytosis of C. albicans 
Genistein was reported to be a tyrosine kinase inhibitor with a rather broad specificity so 
that a number of signal transduction cascades could be influenced. Interactions of the pathogen  
C. albicans with host cells frequently lead to internalization of the yeast by processes such as 
endocytosis and phagocytosis. Endocytosis is of major relevance for non-phagocytotic host cells, 
such as vascular endothelial cells; whereas phagocytosis is an important function of macrophages. 
Both processes involve the phosphorylation of tyrosine residues and it was reported that 
endocytosis of C. albicans was significantly reduced by pretreatment of endothelial cells with 
genistein (100 µM) [32]. As phosphorylation of tyrosine residues are also downstream reactions 
of pathogen recognition by phagocytosis receptors [166], we investigated the influence of 
genistein on the phagocytosis of C. albicans by macrophages. As shown in Fig. 4.24, treatment of 
the macrophages with genistein reduced the phagocytosis efficiency in a time- and 
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dose-dependent manner. Pre-treatment of the macrophages with genistein for 2-8 hours did not 
influence the phagocytotic effect. However, when the pre-incubation time was extended to 24 
hours, phagocytosis of C. albicans was decreased to 50% of the control by 25 µM genistein; and 
to about 80 - 90 % by 12.5 µM genistein, with a slight recovery after prolonged phagocytosis 
times (60 min). After 48 hours, the effects were even more pronounced, as the higher 
concentration (25 µM) led to the strong inhibition to 40%, and the lower concentration (12.5 µM) 
to less than 70%. The inhibition effect was observed throughout the whole observation period.  
 
 
 
 
Fig. 4.24 Phagocytotic activity of RAW264.7 
macrophage for C. albicans CAF2-1 after treatment 
with different concentration of genistein for 2-8 h 
(A), 24 h (B), and 48 h (C). The yeast cells were 
fluorescently labeled and the amount of internalized 
yeasts was determined after the indicated times (30 
min, 45 min, and 60 min) by a multiwell - 
fluorimeter. White bars are 25 µM genistein; grey 
bars are 12.5 µM genistein. Data are given with 
respect to the solvent control and are the results of 
three independent experiments.  
 
4.3.3 Cytokine production of genistein treated macrophages with C. 
albicans 
We had observed that genistein reduced the cytokine production of LPS stimulated 
macrophages (4.1.7). As LPS mainly activates signal transduction cascades downstream of TLR4, 
whereas C. albicans also interacts with TLR2 and dectin-1, the influence of genistein on cytokine 
production by macrophages, which were stimulated with C. albicans, was also tested. 
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Macrophages were treated with genistein 1 hour before C. albicans was added. The supernatant 
was discarded after genistein treatment and the yeast suspension without genistein supplement 
was added, so that genistein could not influence C. albicans. As shown in Fig. 4.25, genistein led 
to a pronounced inhibition of TNF-α and IL-10 production after 1.5 and 5 hours infection times.   
 
Fig. 4.25 TNF-α and IL-10 production of macrophages in response to C. albicans CAF2-1, influenced by 
genistein. The results represent two independent experiments, and data are the mean ± S.D. of at least 4 single 
values of each experiment.  
**: p<0.01 compared with DMSO control. 
4.3.4 Interaction of genistein-treated C. albicans with RAW264.7 
macrophage 
Genistein influenced the respiratory activity of C. albicans, the endogenous ROS 
accumulation, and cell surface hydrophobicity (4.2). As cell surface hydrophobicity may 
influence also the interactions to host cells, we tested whether genistein treatment of C. albicans 
could influence the degree of internalization by macrophages. The effect of genistein treatment of 
C. albicans on the time course of phagocytosis is shown in Fig. 4.26. Already at the earliest time 
point of 15 minutes incubation time of C. albicans with macrophages, the level of phagocytosis 
was significantly enhanced and this effect lasted during the whole experimental period of 60 
minutes.  
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Fig. 4.26 . Phagocytosis of genistein treated C. albicans CAF2-1 by the macrophage cell line RAW 264.7. 
Data represent the mean ± S.D. for at least 6 single values in each experiment, each experiment was repeated 3 
times. **: p<0.01; *: p<0.05 comparison with DMSO control. 
 
4.3.5 Cytokine production of RAW264.7 macrophages stimulated 
with genistein-treated C. albicans  
As we had observed an enhanced phagocytosis of genistein-treated C. albicans, we 
evaluated whether genistein treatment also influenced cytokine production. In Fig. 4.27, data are 
shown for the production of TNF-α and IL-10. Contrary to the results obtained, when 
macrophages were treated with genistein, the pre-incubation of C. albicans with genistein led to a 
significant enhancement of TNF-α concentrations and also to an increase of IL-10 concentrations 
(p<0.01). 
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Fig. 4.27  Effects of genistein treatment of C. albicans CAF2-1 on the production of TNF-α (A) and 
IL-10 (B) by macrophages; the results represent two independent experiments, the data for each experiment are 
the mean of at least 4 single values of each experiment. **: p<0.01 comparison with DMSO control. 
 
4.4 Interaction of C. albicans single gene deletion mutants with 
macrophages 
4.4.1 Phagocytosis  
As we had observed that treatment of C. albicans with genistein influenced the interaction to 
RAW264.7 macrophages, we used single gene deletion mutants of C. albicans to identify fungal 
pathways which are involved in this interaction. MAP kinase pathways and the histidine kinase 
Chk1p are involved in the cell wall structure of C. albicans [167, 168]. Therefore, we investigate 
whether there is any relation between MAP kinase pathways and histidine kinases, which may be 
the sensor proteins of the MAP kinases cascades. The MAP kinase mutants (∆cek1, ∆mkc1, and 
∆hog1) and MAPK kinase mutants (∆hst7 and ∆pbs2) were used together with the histidine 
kinase mutant ∆chk1 and the reference strain CAF2-1 in the phagocytosis assay. 
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Fig. 4.28 Phagocytosis of MAP kinase mutants (∆cek1, ∆mkc1, and ∆hog1) and MAPK kinase mutants 
(∆hst7 and ∆pbs2) by RAW264.7 macrophages in comparison to the reference strain CAF2-1 and histidine 
kinase mutant ∆chk1. The phagocytosis time was one hour. The figure shown above is the mean ± standard 
deviation of three independent experiments. **: p<0.01; *: p<0.05 comparison with CAF2-1. 
 
Among the mutants, the MAP kinase mutant ∆hog1 showed only a small increase in 
phagocytosis efficiency compared with the reference strain (CAF 2-1). The mutant ∆pbs2 showed 
another slight increase which was to be regarded as significant. In contrast, the other MAP kinase 
mutants, ∆cek1 and ∆mkc1, and the respective MAPK kinase mutant ∆hst7 were internalized 
significantly better by the RAW264.7 cells than the reference strain CAF2-1 (Fig. 4.28). Thus, 
effects from these strains were investigated further. 
 
4.4.2 Cell wall β-glucans and mannans exposure of C. albicans 
mutants 
β-1,3-glucans are reported to be essential for the recognition of C. albicans by the 
macrophage receptor dectin-1, the main receptor for phagocytosis of C. albicans. A previous 
study had shown that cell wall mannans of CHK1-deficient C. albicans were significantly 
truncated [169]. As in C. albicans the inner β-glucan layer of the fungal cell wall is known to be 
shielded by these mannan chains [54, 170], these shorter mannans could lead to an increased 
exposure of the β-glucans for immune recognition. Thus, the accessibility of β-1,3-glucans and 
mannans of MAPK and MAPK kinase mutants was evaluated in comparison to ∆chk1 and the 
parental strain CAF2-1. Antibody-staining of the β-1,3 -glucans of CAF2-1 resulted in only poor 
fluorescence intensities of about 500 RFU (Fig. 4.30), whereas the MAPK and MAPK kinase 
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mutants as well as ∆chk1 were efficiently stained and achieved high median fluorescence 
intensities indicating a high amount of accessible β-1,3-glucans compared with CAF2-1 (Fig. 
4.29). In addition, it has to be noted that background fluorescence observed from negative 
controls was similar for all mutants.  
The cell wall mannans were stained with FITC-labeled concanavalin A and analysed by flow 
cytometry. The exposure of mannans of Δchk1 was reduced to 60% of the level of CAF2-1. The 
decrease observed withΔhog1 was not significant.Δpbs2 still had 75% of the signal of CAF2-1, 
whereas all the other MAPK and MAPK kinase mutants showed mannan exposure levels of 
60-70% of CAF2-1.  
 
Fig. 4.29 Overlay of β-glucans expression of MAPK and MAPK kinase deletion mutants in comparison to 
C. albicans CAF2-1. Fluorescence intensity of antibody-labeled yeasts was detected via flow cytometry. The 
overlay of CAF2-1 (white area) and the respective mutants is shown (grey area). The mutants which have a 
higher exposure of glucans are highlighted in red. 
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Fig. 4.30 Quantitative comparison of the median fluorescence intensities of stained mutants and the 
reference strain CAF2-1. Representative data of three independent experiments are shown. 
 
 
 
Fig. 4.31 Mannan exposure of MAPK and MAPK kinase deletion mutants in comparison to CAF2-1 and 
the histdine kinase mutant ∆chk. (A) Yeast cells of the C. albicans mutant strains were stained with FITC 
labelled Concanavalin A. Fluorescence intensity of labeled yeasts was detected via flow cytometry. 
Quantitative comparison of the median fluorescence intensities of stained mutants and the reference strain 
CAF2-1. (B) Percentage of median fluorescence intensities of CAF2-1. Representative data of three 
independent experiments are shown. 
 
4.4.3 Phagocytosis of C. albicans mutants by RAW264.7 
macrophage after genistein treatment 
 
MAP kinase pathways are used by eukaryotic cells to response to changes in the external 
environment. Although there are several differences between mammalian cells and lower 
eukaryotic cells regarding the complexity and functionality of the elements involved, the core 
structure of the MAP kinase cascade is highly conserved [171]. As genistein could activate the 
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MAPK kinase signalling cascade by phosphorylation of MAP kinase p38 and ERK1/2 in 
mammalian cells, we utilized genistein-treated MAP kinase deletion mutants with genistein to 
detect whether genistein could target on the MAPK kinase pathways in C. albicans. We analyzed 
the phagocytic efficiency of macrophages for genistein treated C. albicans mutants. The result 
showed that the phagocytosis efficiency for Δcek1 and Δhog1 was not affected by genistein 
treatment, suggesting that the genistein effect of the wild type could be related to the pathways.    
 
Fig. 4.32 Phagocytosis of genistein treated mutants by RAW264.7 macrophages in comparison to the 
reference strain treated CAF2-1. The phagocytosis time was 45 minutes. The figure shown above is the mean ± 
standard deviation of 4 repeated values. 
 
80                             The cellular and molecular properties of genistein against C. albicans infection 
 
5 DISCUSSION 
5.1 Effects of genistein on the macrophages  
Genistein, an isoflavone, has been shown to inhibit the proliferation of several types of 
cancer cells. However, currently little is known about its effect on macrophages. Our experiments 
focused on the effects of genistein on the murine macrophage cell line RAW264.7. Different 
concentrations of genistein were used to examine the effects of genistein on macrophage 
proliferation, cell cycle, cell morphology and F-actin cytoskeleton structure. 
In this study, the WST-1 method was used to detect cell proliferation. The WST-1 method is 
easier and more sensitive compared with the conventional MTT method. In metabolically active 
cells, the colorless tetrazolium salt is reduced by dehydrogenases to a yellow water-soluble 
formazan. This color change can be detected by a spectrophotometer at the wavelength of 450 nm. 
The results showed that genistein had an inhibitory effect on the cell viability in a time- and 
dose-dependent manner (4.1.1). When the macrophages were treated with genistein for the short 
time of only 2 h, none of the genistein concentrations led to decreased signals. However, when 
the incubation time was extended to 24 and 48 hours, genistein concentrations in the range of 
50-100µM reduced the cell viability. But no influence on the cell viability was observed with 
lower genistein concentrations (12.5, 25 µM). Meanwhile, genistein arrested the macrophages at 
the G2/M phase of the cell cycle in a concentration- and time-dependent manner. When the 
macrophages were treated with genistein for 24 hours, the number of cells in the G2/M phase 
significantly increased when the concentration was 100 or 50 µM, respectively. The effect was 
more striking when the incubation time was extended to 48 hours. Lower concentrations (25 and 
12.5 µM) of genistein had no obvious effect on the cell cycle, suggesting that the reduction of cell 
viability was due to reduced cell proliferation, which was due to cell cycle arrest (4.1.2).  
Genistein treatment also altered the morphology of RAW264.7 cells via influencing the actin 
cytoskeleton structure (4.1.3-4.1.4). An inverted contrast microscope was used to observe the 
cells treated with genistein for 2, 24, and 48 hours. Aberrations in cellular morphology were 
observed and the morphological changes were time- and dose-dependent. The different 
concentrations of genistein exerted no effects on the morphology after 2 hours of treatment. After 
24h, genistein-treated cells were well attached, but the cell size increased and showed irregular 
shapes such as diamond shapes or pseudopodia-like protrusions. After 48h, these morphological 
5  Discussion                                                                                          81                      
 
changes became even more obvious. The morphology change is consistent with the results from 
cell proliferation and cell cycle. 
As the morphology of cells is at least partly determined by the cytoskeleton, we investigated 
the structure of the actin filaments in cells, which were treated with genistein. We could clearly 
observe the elongated actin filaments leading to the above mentioned protrusions, and the spindle 
morphology with actin filaments at the edge of the cells. The effect of genistein occured after a 
longer treatment time than effects of cytochalasin B (an actin polymerization inhibitor), which 
exerts its effect already after 2 hours [152]. Therefore, we speculated that the genistein effect 
could be a secondary effect, such as the result of inhibition of different tyrosine kinases in actin 
signal transduction pathways, which subsequently may result in changes in cytoskeleton 
dynamics. The results also showed that genistein caused the changes via different mechanism 
than the cytoskeleton inhibitor cytochalasin B. The results laid a basis for further investigations, 
especially on the phagocytic function of macrophages for C. albicans.  
Genistein has been reported to suppress tumor cell growth, an effect which is mediated by 
different types of cell cycle arrest in the G2/M phase in the several tumor cell lines. Examples of 
such tumor cells include hepatoma cells, breast cancer cells, neoplastic human mammary 
epithelial cells, lung cancer cells, gastric cancer cells, and prostate cancer cells [156, 172-176]. 
Recent studies have shown that genistein can block the human epithelial cell line A549 cells in G 
2/M phase, alter their morphology, and depolymerise interphase microtubules [177]. MAP kinase 
pathways were shown to be implicated in G2/M phase regulation and genistein may exert its 
influence on the cell cycle via activation and inhibition of distinct MAP kinase pathways [47-49]. 
Our results showed for the first time that genistein inhibited the proliferation of macrophages via 
arrests of cells in the G2/M phase in high concentrations. But whether genistein could activate the 
p-ERK1/2 and p-p38 of macrophage needs to be further investigated.  
In conclusion, our comprehensive results clearly showed that only extended incubation of 
macropahges with genistein affected proliferation, cell cycle, cell morphology, and cytoskeleton 
structure. The results provided a basis for further studies of genistein on macrophage functions.  
5.2 Genistein shows a strong anti-inflammatory effect on 
LPS-stimulated macrophages 
Genistein has a variety of pharmacological effects, such as anti-cancer, anti-inflammatory, 
immune modulatory, and cardiovascular protection effects. Excessive secretions of inflammatory 
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factors can cause severe disease such as septic shock. Effective regulation of pro-inflammatory 
cytokine secretion has a potential clinical application as it will effectively control the 
inflammatory response, but could also lower the infectivity of some opportunistic pathogens such 
as C. albicans and Aspergillus fumigatus. However, the anti-inflammatory effects of genistein in 
particular on activated macrophages RAW264.7 had not been investigated in depth. Therefore, 
we studied effects of genistein on the response of macrophages to LPS, IFN-γ, and IFN-γ + LPS. 
A possible mechanism of genistein especially on LPS-activated macrophages is discussed. 
LPS is a membrane component of gram-negative bacteria, acts as an endotoxin and elicits 
strong immune responses in animals. It activates macrophages via the Toll-like receptor 4 signal 
transduction pathway to activate nuclear transcription factors NF-κB and AP-1, leading to a 
release of inflammatory mediators like NO, TNF-α, IL-1β, IL-6, and IL-10. Thus, in the 
laboratory, LPS mimics the inflammation state in the body. Genistein could strongly inhibit 
LPS-induced NO and secretion of inflammatory cytokines TNF-α, IL-6, and IL-10 in the 
RAW264.7 macrophages in a dose-dependent manner. It has been reported that pre-treatment 
with genistein before intraperitoneal injection of LPS in a murine inflammation model 
significantly lowered the serum levels of TNF-α in vivo [178]. Moreover, genistein significantly 
inhibited cytokine-induced increases of TNF-α, interleukin-1β, IL-8 mRNA, and protein 
expression of inflammatory mediators in human brain microvascular endothelial cells [179]. Our 
results confirmed that genistein has a potential anti-inflammatory effect.  
IFN-γ is a cytokine that is critical for innate and adaptive immunity against viral and 
intracellular bacterial infections as well as for tumor control. IFN-γ not only inhibits viral 
replication but also shows immunostimulatory and immunomodulatory effects [180]. Aberrant 
IFN-γ expression is associated with a number of autoinflammatory and autoimmune diseases. 
IFN-γ activates the Jak-STAT pathway in macrophages and induces production of NO and 
cytokines. Genistein strongly abrogated both IFN-γ-induced and LPS-induced release of NO in a 
similar way. The effect of the genistein on the IFN-γ pathway is currently not well understood. 
Our results showed for the first time that genistein also influences the IFN-γ-activated Jak2-STAT 
signalling transduction pathways. 
Tyrosine phosphorylation is one of the earliest events to occur in response to an immune 
challenge, but the role of specific tyrosine kinases in inflammatory cytokine production has been 
difficult to ascribe due to conflicting literature. As genistein is a broad range tyrosine kinase 
inhibitor, we additionally applied specific tyrosine kinase inhibitors (Jak2, Syk, and Src 
inhibitors), MAP kinase inhibitors (SB203580, PD98059), inhibitors of down-stream kinases (PI3 
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kinase and Akt kinase inhibitors), and a protein phosphotyrosine phosphatase inhibitor (Bpv 
(phen)). We found that both tyrosine kinases Jak2 and Syk are essential for NO production as a 
response to LPS and IFN-γ activation. Until now, only Jak2 is known to be involved in the IFN-γ 
signaling pathway, our results now showed the decisive role of tyrosine kinase Syk. However, we 
did not find an essential role for the MAP kinase ERK and the protein phosphotyrosine 
phosphatase in both the LPS and the IFN-γ pathway, and p38 was required only for LPS 
stimulated NO production. The results do not correlate with another report, in which an 
regulating role of the ERK pathway in the IFN-γ-induced macrophage NO production and an 
enhancement by phosphatase inhibition was observed [181]. However, all kinases and 
phosphatases were involved in TNF-α, IL-6, and IL-10 production in a dose-dependent manner. 
The results suggest that the different kinases and the phosphatase functions in a dose-dependent 
manner. As tyrosine phosphorylation is one of the rapid responses to the stimulus, after a long 
time period stimulation like in the NO assay, the effect of some kinases could be compensated by 
the cross talk with other pathways. From these results, we concluded that the MAP kinases, 
ERK1/2, and p38 are involved in the short time response of LPS activation for cytokine 
production; whereas, tyrosine kinases are involved in both processes. This could explain the 
inhibitory effect of genistein, a broad spectrum tyrosine kinase inhibitor, on NO and cytokines 
production independent of the stimulus. 
To further delineate and confirm the signalling processes involving MAP kinases in the 
regulation of LPS-induced activation of macrophages by genistein, we evaluated the induction of 
their phosphorylation by western blot analysis (4.1.9). LPS led to the phosphorylation of Raf, 
MEK1/2, and ERK1/2 already after 15 min post-stimulation and it sustained till 30 minutes. 
Phosphorylation of p38 was also observed, but it was not as obvious as p-ERK1/2. The results 
also proved that both p38 and p44/42 mitogen-activated protein kinases are involved in LPS 
activation of RAW264.7, which is also partly confirmed in the literature [162]. Addition of 
genistein further increased the phosphorylation of ERK1/2, of its downstream protein p90rsk and 
of p38. These results differed from the ones observed by Chu [182], who showed that LPS 
activation of MAPK was significantly depressed by genistein, SB 203580, and PD 98058 in the 
human monocytic THP-1 cells. The discrepancy between our results and those reported 
previously could be due to the different cell lines, the pre-treatment time for inhibitors, and the 
stimulation times for LPS. Meanwhile, genistein has been reported to selectively potentiate 
arsenic trioxide-induced apoptosis in human leukaemia cells via activation of p38 
mitogen-activated protein kinase [48]. Our results were the first to suggest that genistein activated 
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p-p38 and p-ERK1/2 in LPS-stimulated macrophages, but the clear mechanism still requires 
further investigation. 
At the transcriptional level, the NF-κB and AP-1 transcription factors play a key role in the 
regulation of inflammation and therefore, in the generation and release of NO and cytokines like 
TNF-α, IL-6, and IL-10. NF-κB plays important roles in the control of cell growth, differentiation, 
apoptosis, and stress-response. Whereas, NF-κB activation is part of the TLR4 signalling pathway, 
and the activation of AP-1 is related to the MAPK signal transduction pathway. To further 
elucidate the anti inflammatory role of genistein, we first used the RAW-BlueTM cells to detect 
the effect of genistein on both the nuclear transcription factor NF-κB and AP-1 (4.1.10). 
RAW-BlueTM cells could stably express the secreted embryonic alkaline phosphatase (SEAP) 
gene, which is induced by activation of either the NF-κB or the AP-1 transcription factor. The 
results showed that genistein significantly reduced the expression of the reporter protein and thus 
inhibited simultaneously NF-κB and AP-1 in a dose-dependent manner.  
In order to study genistein effects on the macrophages at the transcriptional level, we used a 
Toll like receptor pathway PCR array to investigate expression of related genes after different 
treatments (4.1.11). Cells treated with (i) LPS and (ii) LPS together with genistein demonstrated 
significant number of genes to be differentially regulated compared to control cells. Genistein 
alone could up-regulate the gene CD80, MEKK1, c-fos, Rela, and Ticam2. LPS could up-regulate 
20 genes including (a) cytokines IFN-β, IL-10, IL-1α, IL-1β, IL-6, TNF-α, Csf2, and Csf3; (b) 
chemokines Ccl2 and Cxcl10; (c) transcription factor NF-κB1; (d) IκB-α; and (e)  
cyclooxygenase 2 (COX-2). The presence of genistein led to a strong inhibition of the expression 
of these genes and upregulated the transcription factors IκB-β and c-Rel, a subunit of NF-κB. 
Genistein has been shown to inhibit the COX-2 production in LPS-stimulated chondrocytes [183]. 
The results correlate to the data obtained from IL-10, IL-6, and TNF-α protein secretion.  
The results also showed that genistein alone could activate MEKK1 and c-Fos gene 
expressions. Members of the Fos family dimerise with c-jun to form the AP-1 transcription factor. 
In the previous results, we found genistein could inhibit the activation of transcription factor 
NF-κB and AP-1 in the RAW-BlueTM reporter cell line. This results confirmed the knowledge that 
genistein could inhibit the expression of NF-κB1 and IκB-α at the transcriptional level. 
Additionally, these results provide additional evidence for the results from western blot that 
genistein could activate MAP kinase cascade.  
In conclusion, genistein showed a strong anti-inflammatory effect in RAW264.7 
macrophages: it inhibited the secretion of NO and reduced the secretion of inflammatory 
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cytokines such as TNF-α, IL-6, and IL-10 via its effects on the transcription of these proteins. 
Moreover, genistein could strongly regulate the gene expression of cytokines, such as IL-1α, 
IL-1β, IFN-β, Csf-2, and Csf-3, and of chemokines, such as Ccl2 and Cxcl10. The effects of 
genistein could partly be due to tyrosine kinase inhibition of JAK2, Syk, Src and their 
downstream kinase PI3K-AKT pathway leading to the inhibition of the activation of the 
transcription factors NF-κB and AP-1. The results of this study provided more evidence for 
investigation of the mechanism of anti-inflammatory effects of genistein.  
 
Fig. 5.1 Schematic illustration of the inflammation mechanism in macrophage RAW264.7 activated by 
LPS and/or IFN-γ. The kinases which are potentially targeted by genistein based on our results are highlighted 
by a red rectangle.  
5.3 Genistein effects on C. albicans 
Mitochondria are known as the power houses of the cell, they play very important roles in a 
range of processes such as ATP production, electron transport, and oxidative phosphorylation, 
release of caspase-activating proteins, generation of reactive oxygen species (ROS) and changes 
of cellular redox potentials [124]. Due to these properties, mitochondria are considered to be a 
potential target for antifungal agents. Compounds such as rotenone, antimycin, myxothiazols, 
melithiazols and cystothiazoles are known to exert their antifungal activity by specifically 
inhibiting the electron transport within the respiratory chain [125, 126]. In plants, flavonoids are 
also responsible for defense against infections. Flavonoids, such as hispidulin, resveratrol, 
eupafolin, genistein, and flavone, target on the respiratory chain of mammalian cells [184-188]. 
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However, the function of flavonoids, on C. albicans is still unknown. Therefore, it is interesting 
to investigate genistein effects on C. albicans especially on mitochondria.  
Genistein showed an inhibitory effect of oxygen consumption and induced ROS production 
in C. albicans but not in S. cerevisiae, suggesting electron transport chain could be the target of 
genistein. Rotenone, a specific complex I inhibitor, also showed an inhibitory effect of oxygen 
consumption and an increased ROS production only in C. albicans. S. cerevisiae lacks the 
classical complex I and thus is resistant to rotenone, whereas, C. albicans has NADH 
dehydrogenases and complex I.  
Antimycin A is a specific complex III inhibitor, which strongly blocked oxygen 
consumption and significantly increased ROS production both in C. albicans and S. cerevisiae, 
suggesting that inhibition of complex III is prominent for oxygen consumption and ROS 
production for both C. albicans and S. cerevisiae. This result also indicated that genistein did not 
target on the complex III.  
In contrast to S. cerevisiae, C. albicans expresses an alternative oxidase (AOX) that act 
downstream from coenzyme Q. It is induced by inhibitors of complex III and IV, such as 
antimycin A or cyanide [132]. This alternative oxidase is related to cyanide resistant respiration, 
which accepts electrons from the ubiquinone pool of the main cytochrome pathway and reduces 
oxygen to water [132]. There are also reports that reactive oxygen species (ROS), such as 
superoxide radical anions and H2O2 induce the expression of AOX in Hansenula anomala and 
Petunia hybrid, suggesting that the cyanide-resistant respiration may be part of defence system 
against oxidative stress, minimizing the generation of ROS in mitochondria [189, 190]. Since we 
observed an increase in the level of ROS, we excluded the possibility that genistein could target 
on the alternative oxidase. Thus, we assumed that complex I is the most likely target of genistein. 
Complex I is a very large enzyme at the entry point of the mitochondrial electron transport 
chain [191, 192]. It has a complex structure and a number of redox centers involved in the 
electron transfer from NADH to a lipid soluble electron carrier, ubiquinone or Coenzyme Q 
(CoQ). The redox reactions are performed by one non-covalently bound FMN, at least six 
iron-sulfur clusters, and at least two distinct protein-bound species of quinone [193]. The FMN is 
considered to be the direct electron acceptor of NADH and subsequently electrons are transferred 
to the iron-sulphur clusters. N-2 iron-sulphur center is the direct electron donor to endogenous 
ubiquinone. Complex I is also considered to be one of the main sites of reactive oxygen species 
(ROS) production. Electrons leaked at complex I can reduce oxygen and give rise to the 
superoxide anion. N-2 iron-sulphur cluster was reported to be the site of the electron leak, but 
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N-2–ubisemiquinone region, ubisemiquinone, FMN and iron–sulphur cluster N1a have also been 
proposed as electron donors to oxygen [192].  
As the mechanism of superoxide production by complex I is not yet clear due to a lack of 
knowledge about the exact sequence of the electron carriers and on the coupling of the electron 
transfer to proton translocation [192], the mechanism of action of genistein cannot be precisely 
defined. But we propose that genistein could act as a prooxidant by its direct reaction with the 
iron of complex I of the respiratory chain and O2. Cao et al. have proposed a reaction sequence 
for ROS production where the first step requires the oxidized state of the involved transition 
metal, which is reduced by the reaction with genistein [194]. The generation of the hydrogen 
peroxide can be assumed by the following reaction sequence [186, 194]. 
 
GEN-OH is the reduced form of genistein, GEN=O is the oxidized form and Fe3+/2+ is part of  
an Fe-S cluster belonging to the involved respiratory chain complex. 
 We further tested whether genistein influenced the complex I reductase activity. We used 
DCIP as an electron mediator, DCIP is a hydrophilic electron acceptor widely used to test 
complex I reductase activity. It is reported that only 20-30% of this activity is sensitive to 
rotenone [192]. The results showed that genistein and rotenone affect DCIP reduction in a 
different way. Rotenone prevented this reduction, while genistein has no effect. This suggests 
genistein did not target the rotenone sensitive NADH dehydrogenase. Genistein was reported to 
inhibit the activity of complex I in bovine heart electron transport particles but was considered to 
be less active than rotenoid compounds [195].  
As glucose was the carbon source in the cultivations, the main pathway for the carbon 
metabolism was glycolysis. In aerobic organism C. albicans, respiration is the main pathway for 
energy generation [146]. The glucose will convert to pyruvate together with the production of 
adenosine triphoshpate (ATP) and NADH. NADH oxidation in the respiratory chain leads to 
electron transfer from NADH finally to oxygen and production ATP. Inhibitors of respiratory 
chain redirect pathways to fermentation and thus enhance the ethanol and glycerol production 
[148]. Thus, inhibition of the respiratory chain by genistein should influence the ethanol 
production. We confirmed that genistein indeed slightly induced ethanol production at the highest 
88                             The cellular and molecular properties of genistein against C. albicans infection 
 
concentration of 100 µM. 
In conclusion, our results showed that genistein targeted on the respiratory chain of C. 
albicans. We propose that genistein is oxidized by a redox reaction with iron-sulfur clusters and 
thus blocks electron transport and consequently oxygen consumption and induces ROS 
production. Our results also confirmed that growth rates of yeasts are not necessarily correlated to 
respiration rates. The parallel analysis of effects on growth rate and on the oxygen consumption 
rate improves the reliability of the detection of potential inhibitors and gives additional hints on 
the mode of action of compounds [146].  
5.4 Treatment of C. albicans with genistein enhances the 
activity of murine macrophages 
Anti-inflammatory properties of genistein have been investigated. Up to now, most 
experiments are focused on the pre-treatment of different cells of the immune system with 
genistein and on studying the resulting influences on the functions of the immune system. For 
example, macrophages [196-200], neutrophils [201-206] and monocytes [207] were treated with 
genistein prior to stimulation with LPS or infection by different pathogens such as E. coli [208], 
Legionella pneumophila [207], and Cryptosporidium parvum [209]. Usually inhibitory effects on 
the functions of the immune cells were observed, which could be explained mainly by the 
inhibition of tyrosine kinases by genistein. In our study, the effect of genistein on the interaction 
between C. albicans and macrophages was evaluated, particularly, the effects of genistein on 
phagocytosis of C. albicans by macrophages considering two different aspects: genistein acts 
either (i) on the host or (ii) on the pathogen. The results showed that genistein could act on both 
the yeast and the macrophages.  
According to previous reports, tyrosine residues in host cell proteins became phosphorylated 
when host cells interact with C. albicans [31, 32]. As the endocytotic internalization of C. 
albicans by endothelial cells was one of the affected processes [37], we investigated whether 
incubation of macrophages with genistein also influenced internalization of C. albicans by these 
cells, which is mainly due to phagocytosis. We did not observe short-term effects, but extension 
of the incubation time to 24 or 48 hours significantly reduced the phagocytotic activity without 
influencing the cell viability [210]. This observation correlates to the changes in cell morphology 
and in the structure of the actin cytoskeleton, which were also observed only after 48 hours of 
incubation. Previously, it was shown that any interference with the dynamics of the actin 
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cytoskeleton leads to a reduction of the phagocytotic efficiency of macrophages for C. albicans 
[211]. Thus, the inhibition of phagocytosis after extended genistein incubation time may be due to 
secondary effects of genistein on the cytoskeleton.  
However, inhibition of the secretion of the cytokines TNF-α and IL-10 occurred after a 
pre-incubation time of only 1 hour, which indicates direct effects on signal transduction cascades. 
Similar effects of genistein on TNF-α and IL-10 production were observed when macrophages 
were treated with LPS. Moreover, dectin-1 together with Toll-like receptor 2 (TLR2) are involved 
in cytokine production resulting from the presence of C. albicans [84], and the corresponding 
signalling cascades comprise of several tyrosine kinases. FACS analysis showed that dectin-1 and 
TLR2 receptors are expressed on the surface of RAW264.7 macrophages. The inhibitory effects 
of genistein on the production of these cytokines are probably due to the tyrosine kinase 
inhibitory property of genistein. 
Further, we investigated whether treatment of C. albicans with genistein influenced the 
interaction to host cells. We cultivated C. albicans in the presence of genistein overnight to allow 
not only immediate effects, but also secondary effects such as the cell wall composition, which is 
the primary point of interaction to host cells. Contrary to the results obtained when macrophages 
were treated with genistein, we observed an enhanced level of phagocytosis and also a stimulated 
production of the cytokines TNF-α and IL-10. It was reported that released TNF-α can have a 
positive feedback on phagocytosis at early stages of infection [212]. Therefore, the increased 
secretion of TNF-α may be the reason for the enhanced phagocytosis of C. albicans.  
Moreover, the increased cell surface hydrophobicity resulting from genistein treatment of C. 
albicans points to influences on the cell wall composition. These may affect its interaction with 
macrophages via either specific receptor-ligand interactions or changes in physicochemical 
properties, since cell surface hydrophobicity of C. albicans cells affects adherence of C. albicans 
to host tissues [213]. However, genistein treatment of C. albicans did not influence β-1, 3-glucan 
exposure so that specific dectin-1 activation cannot be considered to be the reason for the positive 
effects on the macrophage functions. The respective mechanisms are yet unknown and their 
elucidation is a topic for further studies.   
MAPK kinase cascades are involved in several stress resistance mechanisms: regulation of 
cell wall biosynthesis, morphogenesis, and virulence [118, 121, 167]. In particular, 
CEK1-mediated mitogen-activated protein kinase pathway controls C. albicans β-glucan 
exposure and modulates immune responses [214]. Our results showed that the MAPK mutants 
have a high phagocytotic uptake efficiency compared with the parental strains CAF2-1, which is 
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related to higher β-glucans exposure. Cek1p, Mkc1p, Hst7p, and Pbs2p are reported to regulate 
the virulence of C. albicans in in vivo experiments [167]. We used genistein to pre-treat the 
mutants Δhog1 and Δcek1, then infected the macrophages. The results showed no influence of 
genistein on the phagocytosis of the mutants compared with solvent control, suggesting that these 
pathways are involved in the genistein effect on phagocytosis.  
In conclusion, we studied the effects of genistein on the interaction of C. albicans with 
macrophages, using primarily phagocytosis and cytokine production as indicators. Genistein 
exerted dose- and time-dependent inhibitory effects when macrophages were pre-treated with 
genistein. However, genistein also showed the ability to modify the cell surface of C. albicans so 
that the cell surface became more hydrophobic and enhanced the activity of murine macrophages. 
Thus, our studies point to new pharmacological activities of genistein and alternative 
strategies for immunostimulation in host-pathogen systems by treating the immune cells as well 
as the pathogen.  
5.5 Conclusions and future directions 
Flavonoids belong to a class of phytochemicals with remarkable chemical and biological 
properties. Since ancient times, humans have exploited the therapeutic properties of medicinal 
plants, many of which have been found to have flavonoids as their primary active constituent. 
Isoflavones are a subclass of flavonoinds which is found mainly in soybeans, which are mostly 
consumed in Asian countries like China and Japan in the regular diet. The target compound 
genistein is one of the most important isoflavones. Research on the health benefits of genistein 
over the last century has elucidated the effects as antioxidant, anti-inflammatory, anti-microbial, 
cardioprotective, and anti-cancer compound. 
Fungal infections are a severe medical issue in particular for patients with a compromised 
immune system. C. albicans infections have risen steadily over the past three decades. 
Approximately 70% of women experience vaginal infections and 20% of them suffer from 
recurrent infections. In those latter recurrent infections, about half of the patients have four or 
more episodes per year [215].  
The immune system has two principal components: innate and adaptive immunity, which 
work together to protect the body against infections. The cells of the innate immune system 
represent the first line of defense in the immunosurveillance network; they directly recognize a 
wide variety of microorganisms through highly conserved receptors and essential microbial 
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molecules. Meanwhile, the immune system carries out its important defensive function in 
intimate and coordinated interactions with the nervous and endocrine systems. Compromised 
immune system increases risks of opportunistic infections and uncontrolled neoplastic tissue 
growth, while an over-activated immune system could also lead to inflammation, allergy, and 
autoimmunity.  
Currently, several classes of systemic antifungal compounds are applied in clinical therapy. 
The application of these antimycotic agents is challenged by the increasing numbers of resistant 
strains and by severe side effects. Drug resistant strains cause tremendous economic damage and 
life-threatening diseases in both immunocompromised and immunocompetent individuals.  
Thus, there is an increasing need to develop new agents, which utilize new targets against 
fungal human pathogens, reduce the risk of resistance development and maintain an efficient and 
equilibrated immune system.  
The research undertaken in this thesis was designed to:  
 Identify potent effects of genistein on the properties of the immune cells including 
anti-inflammatory effects of genistein against stimuli from bacteria and cytokines and 
elucidate the underlying mechanisms 
 Determine the molecular effects of genistein on the pathogen C. albicans focusing on the 
modulation of the mitochondria function of C. albicans 
 Examine the effects of genistein on the interaction of macrophages and C. albicans   
 Examine the role of single gene deletions on the interaction of macrophage and C. 
albicans and on the activity of genistein  
The elucidation of the mechanisms of action of genistein against C. albicans infection listed 
above is a challenging task. A multitude of chemical and biological properties of genistein may 
together collaborate in the anti-inflammatory and anti-fungal effects. The findings outlined in this 
thesis provide the basis for piecing together a mechanism explaining the properties of genistein 
against C. albicans infection.  
We have demonstrated that genistein induces a cell cycle arrest in G2/M phase and 
influences cell proliferation in high concentration (50-100 µM) with long time incubation (24-48 
h). Treatment of the macrophages with genistein for 24 or 48 h also led to significant 
morphological changes, such as elongation of the cells and development of long pseudopodia-like 
protrusions. By staining the F-actin cytoskeleton, we observed the accumulation of 
actin-filaments at the edges of the cells.  
Genistein influences the function of macrophage challenged by different stimuli such as LPS 
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and cytokines like IFN-γ. It showed a strong anti-inflammatory effect, while the precise 
mechanism underlying this inhibition still remains to be further determined. Possible mechanisms 
include: (i) inhibition of the secretion of NO; (ii) reduction in the secretion of inflammatory 
cytokines TNF -α, IL-6, and IL-10 protein levels via influencing of their transcription; and (iii) 
strong regulation of the expression of (a) cytokines IFN-β, IL-10, IL-1α, IL-1β, IL-6, TNF-α, 
Csf2, and Csf3; (b) chemokines Ccl2 and Cxcl10; (c) transcription factor NF-κB1; (d) IκB-α; and 
(e) cyclooxygenase 2 (COX-2). It could be due to tyrosine kinase inhibition of Jak2, Syk, and Src 
and their downstream kinase PI3k-Akt pathway, which leads to the inhibition of the transcription 
factors NF-κB and AP-1. 
Additionally, we investigated whether genistein directly influences the pathogen C. albicans. 
Our results showed that genistein blocked oxygen consumption of C. albicans and induced the 
production of reactive oxygen species which means that genistein could influence the function of 
mitochondria of C. albicans. The respiratory chain structure of C. albicans is more complex and 
flexible than that of mammalian cells. It is not yet fully elucidated. Therefore, this brings a 
challenge to the work. The site of action by genistein in complex I and the question of whether 
genistein induces AOX expression are still to be investigated.   
We further studied the effect of genistein on the interaction of C. albicans with macrophages, 
using primarily phagocytosis and cytokine production as indicators. After treatment of the 
macrophages with genistein, the phagocytotic efficiency for C. albicans was decreased in a time- 
and dose-dependent manner. Moreover, the production of cytokines (TNF-α and IL-10) 
stimulated by C. albicans was strongly inhibited by genistein. The inhibition of phagocytosis 
after extended genistein incubation may be due to indirect effects on the cytoskeleton. On the 
other hand, treatment of C. albicans with genistein enhanced the susceptibility of the pathogen 
for phagocytosis by the macrophages and increased the production of the cytokines IL-10 and 
TNF-α. However, genistein did not influence the layered structure of the cell wall but C. albicans 
became more hydrophobic. 
All investigations in this study were performed as in vitro experiments. It is reported that 
genistein also shows protection of the actue lung injury in vivo. However, little is known about 
the function of genistein in more complex systems. And the effect of genistein on C. albicans 
infection should be extended to in vivo experiments. Moreover, the mode of action of genistein on 
C. albicans still needs to be further investigated by microarray and protein analysis. Moreover, 
whether there is a direct link between the inhibition of respiration and the modulation of 
inflammatory responses to C. albicans by macrophage or not still needs to be further studied.  
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The advantage of genistein is that it shows not only anti-fungal but also strong 
anti-inflammatory effects. It can target pathogens and modulate the immune condition of the body. 
Our studies pointed to new pharmacological activities of genistein and alternative strategies for 
immunostimulation in host-pathogen systems by treatment of the pathogens instead of the 
immune cells. As a future research direction, it will be interesting to modify the structure of 
genistein by altering its functional groups to enhance the antifungal effect and then further 
identify the medical potential of the new compounds. 
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 7 APPENDIX    
                   Description of the genes included in the TLR pathway cluster  
Gene 
Symbol
Gene name Aliases Gene bank Gene function Average Ct 
1  2  3  4  
CCL2 Chemokine (c-c motif) ligand 
2 
MCP1,monocyte 
chemoattractant 
protein-1 
NM-011333 C-C chemokine activity 25.9 21.04 20.75 24.93 
Ly96 Lymphocyte antigen 96 ESOP-1, MD-2, 
MD2, MGC151162 
NM-016923 Adaptor protein 
28.74 28.31 24.98 27.7 
Ly86 Lymphocyte antigen 86 MD-1 NM-010745   Adaptor protein 24.67 23.28 23.95 21.4 
Irak2 Interleukin-1 receptor-
associated kinase 2 
6330415L08Rik, 
AI649099, IRAK-2, 
MGC102586 
NM-172161 Adaptor protein 
26.28 25.62 22.97 26.87 
Nfkbib Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor, beta 
IKB-beta, 
IKappaBbeta, IkB, 
IkBb, MGC36057 
NM-010908 Inhibitor of NF-κB 
33.05 32.56 28.45 32.69 
Rel Reticuloendotheliosis 
oncogene 
c-Rel NM-009044 Transcription factor 
27.11 25 22.72 25.76 
Hmgb1 high-mobility group box 1  NM_002128 Adaptor protein 26.1 26.01 25.5 24.34 
TLR2 Toll-like receptor 2  NM-011905 Receptor 24.54 24.46 22.2 24.91 
TLR9 Toll-like receptor 9  NM-031178 Receptor 33.32 33.69 29.54 29.9 
fos FBJosteosarcoma oncogene c-fos NM-010234 Transcription factor 22.77 24.84 22.7 20.72 
CD80  CD80 antigen Cd28l,Ly-53 NM-009855 TLR signalling 28.3 29.05 28.01 30.6 
CD86 Cluster of Differentiation 86 CD28 antigen ligand NM-006889 TLR signalling 35 32.19 32.73 34.98 
Rela V-rel reticuloendotheliosis 
viral oncogene homolog A 
(avian) 
p65 NM-009045 Transcription factor 
23.97 25.57 23.01 25.31 
MEKK1 Mitogen activated protein 
kinase kinase kinase 1 
MAPKKK1,Mekk,M
FKK1 
NM-011945 Protein-kinase,Ser/Thr (non-
receptor) 29.65 30.71 28.26 27.52 
Ticam2 Toll-like receptor adaptor 
molecule 1 
TICAM-1, TRIF NM-174989 Adaptor protein 
29.12 28.27 26.31 28.74 
Csf2 Colony stimulating factor 
2(granulocyte-macrophage) 
GM-CSF NM-009969 Secreted proteins-
hematopoeitins 35 27.39 32.08 35 
Csf3 Colony stimulating factor 3 
(granulocyte) 
G-CSF NM-009971 Secreted proteins-cell 
proliferation  35 21.92 23.11 35 
Cxcl10 Chemokine (C-X-C motif) 
ligand 10 
C7, CRG-2, INP10, 
IP-10, IP10, Ifi10, 
NM-021274 C-C chemokine activity 
32.25 25.28 24.95 29.01 
 Scyb10, gIP-10, 
mob-1 
Ifnb1 Interferon beta 1, fibroblast IFN-beta, IFNB, Ifb NM-010510 Cytokine-inflammatory 
response 35 30.17 30.17 35 
IL10 Interleukin 10 IL-10,cytokine 
synthesis inhibitory 
factor 
NM-010548 Cytokine-inflammatory 
response  
31.58 23.85 25.66 28.6 
IL1a Interleukin 1 alpha IL-1α NM-010554 Cytokine-inflammatory 
response  33.6 23.23 26.35 35 
IL1b Interleukin 1 beta IL-1β NM-008361 Cytokine-inflammatory 
response  35 21.86 22.52 31.71 
IL6 Interleukin  6 IL-6 NM-031168 Cytokine-inflammatory 
response  35 30.15 31.73 35 
Nfkb1 Nuclear factor of kappa light 
chain gene enhancer in B-cells 
1, p105 
NF-kappaB1, p50 
subunit of NF-
kappaB, p50/105 
NM-008689 Transcription regulator 
26.2 22.63 23.23 24.83 
tnfaip3 Tumor necrosis factor, alpha-
induced protein 3 
Zinc finger protein 
A20 
NM-009397 Ubiquitin-editing enzyme 
27.84 25.99 25.14 28.03 
nfkbia Nuclear factor of kappa light 
chain gene enhancer in B-cells 
inhibitor, alpha 
I(Kappa)B(alpha) NM-010907 Inhibitor of NF-κB 
26.76 26.36 25 25.92 
peli1 Pellino 1 -- NM-023324 Adaptor protein 26.88 24.96 23.96 26.73 
ptgs2 Prostaglandin-endoperoxide 
synthase 2 
COX2,cyclooxygena
se 2 
NM-011198 Prostaglandin and leukotriene 
metabolism  28.18 21.77 22 26.58 
TLR3 Toll-like receptor 3  NM-126166 Receptor 28.88 26.48 26.2 28.68 
TLR7 Toll-like receptor 7  NM-133211 Receptor 26.56 25.19 25.41 24.69 
TLR8 Toll-like receptor 8  NM-133212 Receptor 30 29.28 30.52 30.96 
TNF Tumor necrosis factor  DIF, MGC151434, 
TNF-alpha, TNFSF2, 
TNFalpha, Tnfa, 
Tnfsf1a 
NM-013693 Cytokine-inflammatory 
response  
25.61 23.1 21.57 24.48 
Note: 1: Genistein- treated (50μM) macrophages RAW 264.7; 2: LPS -treated (100 ng/ml) macrophages RAW 264.7; 3: LPS+ Genistein treated macrophages RAW 
264.7;  4 : control 
 
